Rowan University

Rowan Digital Works
Theses and Dissertations
7-18-2017

High throughput analysis of the penetration of iron oxide/
polyethylene glycol nanoparticles into multicellular breast cancer
tumor spheroids
Jonathan Robert Gabriel
Rowan University

Follow this and additional works at: https://rdw.rowan.edu/etd
Part of the Biomedical Engineering and Bioengineering Commons

Recommended Citation
Gabriel, Jonathan Robert, "High throughput analysis of the penetration of iron oxide/polyethylene glycol
nanoparticles into multicellular breast cancer tumor spheroids" (2017). Theses and Dissertations. 2454.
https://rdw.rowan.edu/etd/2454

This Thesis is brought to you for free and open access by Rowan Digital Works. It has been accepted for inclusion
in Theses and Dissertations by an authorized administrator of Rowan Digital Works. For more information, please
contact graduateresearch@rowan.edu.

HIGH THROUGHPUT ANALYSIS OF THE PENETRATION OF IRON
OXIDE/POLYETHYLENE GLYCOL NANOPARTICLES INTO
MULTICELLULAR BREAST CANCER TUMOR SPHEROIDS

by
Jonathan Robert Gabriel

A Thesis

Submitted to the
Department of Mechanical Engineering
College of Engineering
In partial fulfillment of the requirement
For the degree of
Master of Science in Mechanical Engineering
at
Rowan University
March 10, 2016

Thesis Chair: Vince Beachley, Ph.D.

© 2016 Jonathan Robert Gabriel

Dedication
For my parents, Michael and Traci Gabriel, and my grandmother Fredelle.

Acknowledgements
I would like to thank my advisor Dr. Vincent Beachley for his direction,
mentoring, and insightful advice during my graduate career. I wish also to
thank my Advisory Committee members Dr. Tom Merrill, Dr. Jennifer Vernengo,
and Dr. Wei Xue, for your efforts I am truly grateful.
Thank you Dr. Robi Polikar for the introduction to Rowan's graduate
engineering program by way of panel discussion at The College of New Jersey in
the fall of 2013. Your enthusiasm piqued my interests to consider the budding
ground of Rowan University as a prime location to continue my education.
I am grateful to the philanthropist and humanist, Henry Rowan for
inspiration and motivation stemming from his ironic quote, "My only regret is
that I did not work hard enough," shared with me by Dr. Merrill. Thank you for
making this unique learning experience possible.
Most importantly, I would like to recognize the support of my parents,
Michael and Traci Gabriel, my brother Eric, my grandmother Fredelle, and all
other close family and friends who provided encouragement during this process.
Through your everlasting guidance and understanding, this work was made
possible, and given meaning beyond the context of these pages.

iv

Abstract
Jonathan Robert Gabriel
HIGH THROUGHPUT ANALYSIS OF THE PENETRATION OF IRON
OXIDE/POLYETHYLENE GLYCOL NANOPARTICLES INTO
MULTICELLULAR BREAST CANCER TUMOR SPHEROIDS
2015-2016
Vince Beachley, Ph.D.
Master of Science in Mechanical Engineering

The purpose of this study was to design and optimize a system for the
high-throughput analysis of multicellular tumor spheroids (MCTS), and validate
the system through the study of a complex biological model. The system was
successfully created and optimized, allowing the histological recovery of MCTS
at rates up to 90% for microarrays of 24-spheroids. Arrays of 96-spheroids were
recovered at rates up to 86%. The system was used to study the penetration of 5k
Da-polyethylene coated superparamagnetic iron-oxide nanoparticles (5k-PEG
SPIONs) into HTB-126 breast cancer spheroids cultured to a mean diameter of
486 µm (± 25.2 µm). Results were compared to an identical study using 2D
cultures. Positive staining for the SPION dosage of 100 µg/mL in 2D culture
regardless of incubation time was observed along with a lack of staining for all
other concentrations in both 2D and 3D. SPION incubation led to necrosis in
breast cancer spheroids after 3 days.
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Chapter 1
Introduction
1.1. Motivation
Biomedical cell culture and analysis techniques developed in the first
decade of the 19th century remain the chosen research methods in many
laboratories of today. Since this time, our fundamental knowledge of cellular
and tissue biology has greatly changed; however, our analytical methodologies
have failed to keep up to pace. It is irrefutable that more efficient tools and costeffective methods are necessary to propel biology, specifically cancer biology and
drug development, through the 21st century. The widespread application of
recent technological advances has the potential to improve outcomes for many
patients now and in the future through improved drugs and personalized
medicine.
It is unfortunate that the pharmaceutical industry is primarily a business
and only secondarily a means for the improvement of humankind. As a result,
more economically favorable products may be pursued in place of developing
those with the greatest potential to impact and cure disease. This idea
substantiates the need for developing testing platforms to produce better drugs
more rapidly, while tailoring them to patient specific needs, at a fraction of the
cost.
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The future of drug development lies in mechanistic approaches which are
superior to their empirical counterparts in identifying novel therapeutic targets.
Many assays for drug development have been developed, but no single assay can
firmly predict the usefulness of a potential candidate. We present a system, with
the ability to interface with existing immunohistochemical techniques that is
high-throughput and uses 3D culture systems as the fundamental diagnostic
tool. 3D culture systems have been proven time and again to be far more
relevant than their out-dated, 2D counterparts. This is because 3D culture
systems accurately represent the 3D tumor microenvironment consisting of cells
and the surrounding extracellular matrix (ECM). Improvements in cellular
biology, tissue engineering, materials science, and micro/nanofabrication will
only benefit the future of 3D culture.
In recent times, innovative discovery techniques have elucidated new
drug targets leading to the development of novel compounds to act upon them.
However, only about 5% of these compounds successfully progress through the
development funnel, ultimately becoming useful treatments. For every 5,000 to
10,000 compounds in the pharmaceutical development funnel, only one will
successfully make it to market. In the United States in 2013, the Food and Drug
Administration approved only 27 new medications; nine of these were orphan
drugs. The European Medical Agency did not surpass this to a great extent,
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recommending 81 medications for approval (up from 57 in 2012). Many drugs
fail during the most expensive phase, phase III clinical trials. The result is a cost
of approximately $1.5 billion USD to bring a single drug to market. This cost is
necessary to make up for failed compounds in a company's pipeline. One
potential reason for the high attrition rate is the use of 2D culture by
pharmaceutical companies as an initial screening tool. The use of 3D cultures in
the pharmaceutical business is likely limited, with little public evidence of any
use. Implications of 2D culture high-throughput screening (HTS) approaches
include the passing of drugs which may ultimately fail, and the screening out of
others which may have become truly beneficial. Additionally, no two patients
ever have the exact same disease state. The term "cancer" refers to over one
hundred different diseases with patient specific genetic effects. There exists a
definite need for a system that can use a patient’s own cells, incorporate the more
relevant 3D microenvironment, and have the ability to be tested and analyzed in
a high-throughput manner. The future of oncology therapeutics is 3D culture,
and there is no reason that it should not be used ubiquitously in 2016.
1.2. Objective
The objectives of this research were as follows: (1) to develop a system or
process for conducting high-throughput analysis of multicellular tumor
spheroids with the ability to acquire regionally based biochemical information,
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and (2) to validate it through a complex biological model involving drug
penetration, showing the power of the methodologies of the system.
The specific aims included: (1) a complete review of the current state of
the field including rationale for 3D culture, spheroid generation methodologies,
and analysis methods amenable to high-throughput testing; (2) optimization of
procedures for the creation and analysis of a spheroid microarray including (a)
microarray mold design and fabrication, (b) spheroid culture techniques, (c)
spheroid harvesting and transfer techniques, (d) microarray fabrication reagents
and techniques, (e) array processing reagents and methodology, and (f)
histological sectioning and staining; (3) quantification of the effectiveness of the
system through (a) determination of the number of spheroids recovered, (b)
degree of tilt during sectioning of the microarray, (c) processing effects of
histological samples, and (d) the value proposition of the system through time
and money saved to a user versus conventional methods; (4) validation of the
system's effectiveness through a 3D study involving two dosages and multiple
time points to characterize the penetration of superparamagnetic iron-oxide
nanoparticles into breast cancer spheroids, and compare these to a parallel 2D
study; (5) develop an automated/mechanical system for spheroid transfer from
culture plates to microarray mold to increase the speed of microarray fabrication
and reduce the cost of the system.
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We hypothesized the system would be capable of recovering at least 90%
of spheroids embedded into blocks of 24-wells through a range equivalent to
one-third of the diameter of the initial spheroid, and at least 70% of spheroids
from blocks of 96-wells through the same range. We anticipate an increased
efficiency of study greater than 1000% compared to conventional methods based
on time and money saved. We believe sectioning will occur in-plane with an
error no greater than 100 micrometers of tilt over the length of the array (0.382
degrees of tilt). Finally, we anticipate dosage and incubation time dependent
effects on nanoparticle penetration in the validation study, but are unsure which
will have a more profound effect.
Future developments related to this project will (1) improve the design of
the mold and process, pushing spheroid recovery above 95% for all array sizes,
(2) fabricate a completely automated system capable of spheroid placement into
the microarray, and (3) improve processing and histological techniques to section
microarrays to 10 µm and below.
1.3. Organization of Thesis
This chapter (Chapter 1) contains an overview of the motivations and
objectives of the research reported in the thesis. This chapter should act as an
outline for the experiments performed, data and results expected, and rationale
for said experiments.
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Chapter 2 is an in-depth and complete literature review on the current state
of 3D culture and its implications for drug development and experimental
biology. Chapter 2 will be condensed and submitted to Pathology & Oncology
Research as a review paper. What differentiates Chapter 2 from other literature
review papers on this topic is its focus on analytical methods for spheroids with
the ability to acquire regionally based biochemical information without ultraexpensive imaging equipment available only in top research laboratories. The
paper then proposes the methods discussed here as a prospective solution.
Chapter 3 consists of a thorough description of the methodologies
invented, refined and analyzed to solve the problem of high-throughput
immunohistochemistry of multicellular tumor spheroids (MCTS). This chapter
represents a bulk of the experimental work of the thesis. The system is complete,
fully characterized, and at a level of quality substantial for formal research.
Recommendations for future iterations of design are recommended. Chapter 3
will be slightly modified and submitted to the journal Tissue Engineering Part C:
Methods.
Chapter 4 contains a validation study for the system, with a comparison
experiment between a 2D and a 3D culture system. It is unfortunate that no
publishable results were obtained from this preliminary study; however, it
remains to show the power of the system, serving its purpose in this thesis. This
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study is currently under repeat and will be combined with Chapter 3 for journal
submission.
Chapter 5 presents a solution for the mechanically automated transfer of
spheroids between culture plates and the microarray mold. Motivation for this
chapter came as the result of suggestions from a recent grant review desiring
more automation in the process. This chapter covers the rationale, design, and
functional procedure. This chapter should be treated as confidential as it
contains drawings and pictures of non-secured intellectual property.
Chapter 6 presents a conclusion of the work in this paper and
recommendations for the future.
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Chapter 2
A Review of 3D Spheroid Cultures as a Tool for Biomedical and Cancer
Research: Needs, Rationale and Implications for the Future
2.1. The Current State of Drug Development
Methods currently employed in biomedical research laboratories and the
pharmaceutical industry to discover novel cancer therapeutics use often
incorporate techniques developed in the first decade of the 19th century. Only as
recently as the 1970s has the industry seen a moderate shift towards more
clinically relevant methods, methods involving the third dimension of cell
culture [1]. More efficient tools and cost-effective methods are needed to
conduct the preclinical screening of anti-cancer drugs to propel these
technologies through the 21st century. Unfortunately, many pharmaceutical
companies operate around the basis of profit and do not necessarily produce the
best possible treatments for patients, but those that are economically favorable.
This idea substantiates the need to develop testing platforms that produce better
drugs more rapidly, while tailoring them to individual needs of patients for a
fraction of the cost.
There is a recent shift in the anticancer drug discovery process from
empirical to mechanistic approaches [2, 3]. Empirical methods involve testing a

8

drug on a culture of cells and measuring the resulting viability1 of the cells
without cognizance for the underlying mechanisms causing change. Mechanistic
approaches revolve around identifying molecular targets as the basis for drug
design. Recent research in genomics and proteogenomics has elucidated many
new molecular targets for researchers and pharmaceutical companies to design
therapeutic agents to act upon [4]. All drugs follow a similar process of design
and development leading to their clinical use. The process begins with
identifying a druggable target as the result of a mechanistic or similar biological
study. Once the target is identified and characterized, in silico modeling is used
to develop an array of lead compounds to act on this target. These compounds
are synthesized, beginning the pre-clinical testing. Difficulties begin with sifting
through large numbers of initial compounds using a set of standardized, highthroughput screens. Both in vitro analyses on appropriate cell lines, and in vivo
studies on relevant animal models are performed. Each drug is fully
characterized using pharmacokinetic and pharmacological tests to determine
absorption, distribution, metabolism and excretion properties. Further
cytotoxicity tests are performed to predict drug safety. The tests determine
potential therapeutic usefulness. Compounds that successfully navigate pre-

viability or another property that is a result of the entire culture’s population. This is in
comparison to a specific cellular event that can be tracked through biochemical analysis to
individual cells or a specific organelle, protein, or gene across many cells.
1
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clinical testing are employed in human clinical trials, the most important of all
tests [1]. Many assays have been developed, but the ability of any particular
assay to predict in vivo efficacy in humans has not been firmly established [4].
While biotech innovations have greatly increased the pool of potential
new therapeutic compounds, only 5-10% of compounds reaching clinical trials
successfully progress through development. For every 5,000 to 10,000
compounds entering the pipeline, only one will make it to market. The large
number of failures along the development process makes the cost of a successful
compound greater than $1.5 billion USD in the 2010s [5]. Failure is generally due
to either a lack of clinical efficacy or unacceptable human toxicity. Clinically
predictive in vitro models have obvious advantages in terms of their ability to
save time and money. Unfortunately, many of the current systems, including
cell-based and xenograft models, are unreliable and non predictive of the
pathophysiology they hope to represent; failure most often occurs during the
latest and most expensive stages of testing, human clinical trials. Therefore, it is
absolutely imperative that more highly predictive, cell-based in vitro models are
created to screen out poorly performing compounds earlier in the development
funnel. Eliminating useless candidates more quickly will reduce costs, wastes,
and the ethical dilemmas associated with clinical trials, especially those of
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failure. Furthermore, it allows prioritizing the most promising candidates and
accelerates their path to market [1].
At this stage, assay methodologies are split into two distinct paths. The
first involves the automation and miniaturization of HTS to create ultra-HTS
approaches, which are considered by some so distant to the in vivo environment
that their outputs are relatively useless [4]. The other path involves creating
assays of intermediate complexity to gain deeper insights to the mechanisms that
operate at the cellular level. Each set of assays has its benefits and limitations.
There are three general categories based on the mode of operation and predictive
capacities [4]. Generic cellular assays study the proliferation, viability and
cytotoxicity in response to external stimuli. These assays are more broad, but
may provide confirmation for the continuation of a compound’s research.
Failure at this step is not necessarily adequate grounds for disqualification.
Other assays study signal transduction pathways such as ion channels, second
messengers, and kinase activation. The third class of assays study events at the
genetic level with regards to transcription, translation and the regulation of such
processes. Unfortunately, none of these assays can definitively predict whether a
compound’s candidacy should be pursued or terminated. The current drug
development process uses a combination of assays to build a library of potential
new compounds that will move on to the next step. Surely many promising
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compounds may be left behind. Additionally, we know that many compounds
passing this stage will fail, costing the system millions of dollars. The lack of
clinical value of these assays may be attributed to the fact that 2D systems do not
accurately predict the 3D environment.
Developments in 3D culture techniques have paralleled research in tissue
engineering, hoping to more accurately represent the 3D microenvironment.
Some techniques able to create reproducible cultures exhibiting viability and
differentiation from isolated primary tissue include spinner flask culture, various
perfusion and fed-batch techniques, and the tumor fragment spheroid model [4].
These methodologies will be discussed further in 2.6 Three Dimensional Culture
Techniques.
Currently, there exists an effort to develop tumor specific testing
platforms that employ the patient's own primary cancer cells. The result is a
highly individualized test which attempts to recreate the specific disease
pathophysiology of the individual patient. One example of these tests is the ex
vivo ATP-based chemosensitivity assay. Unfortunately it relies on the 2D
culturing of tumor cells isolated from primary tissue biopsies [6]. Problems with
this method include a limited number of useful cells extracted from the biopsy,
and the potential modulation of cell morphology upon expansion in 2D culture.
Here, we see a definite need for a system that can use a patient’s own cells,
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incorporate the more relevant 3D microenvironment, and have the ability to be
tested and analyzed in a high-throughput manner.
2.2. The Need for In vitro Models with Increased Physiological Relevance
There is an increased demand for in vitro models that capture more
complexity than what is observed through 2D monolayer culture [7]. It is firmly
established that 2D monolayer culture does not accurately represent the in vivo
micromilieu. The development of tissue and quasi-organ 3D in vitro models
from human cells have the potential to “bridge-the-gap” between standard
monolayer culture, and more complex models such as animal and human testing
[7]. The best method for creating 3D cell structures has yet to be determined, but
it is speculated that better drugs will be developed as a result of testing on more
realistic systems [1]. Initial "stop/go" decisions in the drug development process
are often made after tests on monolayer cultures. These are not the most
physiologically relevant [1]. For the pharmaceutical industry, it is imperative to
screen out poorly performing compounds at the earliest possible stages for cost
effectiveness. Many researchers believe the best way to improve in vitro
screening of candidates is to use 3D multicellular tumor spheroid (MCTS) testing
as a critical part of the process [1]. Since many treatments lose their efficacy in
the 3D environment, spheroids are thought to be a tool for negative selection,
identifying compounds that perform poorly in vivo. More recently molecular
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targets and signaling pathways have been found to play a role exclusively in 3D
making the spheroid model a positive selection tool in drug development
initiatives [8-12].
2.2.1. Predictive capacity of animal, xenograft and humanized models is
limited. Many reports have stated the limited predictive value of routine drug
screening tactics [3, 13, 14]. This information adds additional support to the need
for developing more complex 3D models to adequately mimic the in vivo
pathophysiological environment in hopes of forever replacing monolayer culture
and animal testing [4]. The optimization of preclinical and pre-animal testing
systems will alleviate economical burdens while also diffusing ethical concerns
associated with clinical testing. Additionally, improved tests will optimize and
streamline the selection of clinically effective drugs from the growing pool of
potential candidates [4]. The US National Cancer Institute Developmental
Therapeutic Program uses a few different multi cell-line screens, and one hollow
fiber model, to predict xenograft activity. Xenograft models involve
transplanting human tumors into immunodeficient animals, and studying the
effects of the drug on the tumor. These types of models are thought to be one
step closer to human models than standard animal testing, although they do
come with drawbacks such as unnatural biochemical interactions, and
significantly different, compromised immune systems. As for the cell line
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models, it was shown that the 60-cell line screen was slightly more predictive
than the hollow fiber model in determining which compounds should proceed to
animal and xenograft testing. However, no significant correlation was shown
between any single in vitro or in vivo preclinical model and actual clinical results
[4].
Rodent models will still be necessary for pharmacokinetic2 and
toxicological3 evaluation of potential new therapeutic agents for decades.
However, spheroids have the potential power to greatly reduce the number of
animal models needed, and to delay their use in the process. In this way,
spheroids may not only alleviate ethical and economic concerns, but also make
up for the fact that animal models are not very indicative of human in vivo
testing results, and thus clinical efficacy [4]. MTSC models look to "bridge the
gap" between 2D culture and animal/human testing by employing explanted
human cells in a more natural, and physiologically relevant way. Adding MTSC
as a tool in the drug development arsenal will give researchers a stronger testing
foundation and better information to move forward.
Animal models give researchers information that may not be discerned
from any current in vitro methods, but they often fail to capture the in vivo
response that is seen in humans. For example, the number one reason for the
2
3

dosage, formulation, administration, and half-life
both systemic and organ specific

15

failure of drugs in clinical trials is liver toxicity not predicted by animal models
[15]. Furthermore, many pathogens and immune responses are species specific.
One attempt to create a better model involves ‘humanizing’ mice. Humanized
mice are almost completely immunodeficient mice which show high rates of
human cell engraftment, can support human tissue differentiation and growth,
and generate well-differentiated multilineage human hematopoietic cells after
hematopoietic stem cell transplantation. These models are useful for studying
human hematology and immunology in vivo. More recently, genes have been
introduced into these mice to allow for the production of important human
cytokines with direct influence on the immunological response [16]. These
techniques provide valuable information but remain expensive, challenging and
have limits recapitulating the dynamics of the human body. Questions have also
been raised against the validity of these models as research has shown
fundamental differences in telomerase regulation and cytokine compatibility
between rodents and humans [15].
2.2.2. The engineering journey to more predictive models. To create
increasingly predictive in vitro models, attempts must be made to replicate the
functional hierarchy present in tissues beginning with microvasculature, as
transport phenomena are crucial to understanding biological systems.
Additionally, better models should recreate microscale flows through the
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interstitial space, blood and lymphatic networks, and the apical ducts [7]. The
challenge of recreating microvasculature remains a significant barrier to fully
functional in vitro systems [7]. Microvascular considerations are important for in
vitro models as these mechanisms govern the bulk transport of signaling and
regulatory molecules, along with those required for sustaining life. These flows
lead to a profound impact on tissue proliferation, morphology, and
differentiation in vivo. This will be expanded upon further in Section 2.4, The
Mechanical and Chemical Properties of the In Vitro Microenvironment and their
Influences on Cellular Biochemistry.
The use of a patient’s primary cells for in vivo testing is preferable but
limited by availability. Primary cells have a reduced ability to expand and are
largely variable in morphology. Studies involving human primary cells may also
be hindered by ethical considerations [4]. The lack of primary human material is
the limiting step for high-throughput screening (HTS); systems employing
established cell lines are considered secondary. The result is a demand for more
advanced in vitro test systems based on secondary cells in the pharmaceutical
industry. In tests with secondary material, generating the required number of
cells is no longer an issue; however, tests involving secondary cell lines in place
of those using primary cells may not accurately represent the pathophysiology of
the patient’s specific disease state [4].
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The field of stereolithography has accelerated allowing researchers to
fabricate well toleranced materials into the low end of the microscale range.
These systems are able to produce scaffolds large enough (0.1 - 10 cm) with finely
tuned features such as walls, pores, and channels adequate for cell penetration,
proliferation, communication and pre-vascularization (0.2 - 11 mm). In time,
technology may improve to allow even finer features to facilitate the fine-scale
cell organization truly necessary for in vitro tissue engineered models. Some
manufacturing systems are emerging that allow the necessary resolution to move
into the nanofabrication territory, but these technologies must be properly
adapted to work with biological systems [7].
Many researchers recommend a collaborative environment between
academic institutions and the pharmaceutical industry to prove the predictive
value of 3D systems, while optimizing use and allowing for integration into the
current drug development process. Advances in tissue engineering, such as the
creation of bioreactors and 3D scaffolds, have created numerous new 3D culture
technologies. More work must be done in fully characterizing each of these
systems and evaluating their individual potential to replicate necessary functions
of pathological tumors in vivo [4].
“A principle component of this failure results from our lack of
understanding of, and inattention to, how to culture cells specifically so that they
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phenotypically represent their in vivo counterparts” [17]. It is accepted without
dispute that cells behave in accordance to their environment and culture
conditions. Altering factors such as culture mediums and supplementation,
initial cell density, and culturing surfaces and techniques leads to high variability
in quantitative and qualitative outputs such as proliferation, differentiation,
migration and apoptosis4. It is believed that each of these factors affects both
random and target-specific screening approaches, creating a “butterfly effect” of
cell culture. Further understanding of the cellular microenvironment and its
impact on cellular phenotype is necessary to design increasingly accurate
models.
2.3. Two Dimensional Cell Culture and its Limitations
The fundamental principles of cell culture were first developed in 1907 by
Harrison and colleagues, who showed sustained cell maintenance outside the
original body of origin. Specifically, pre-differentiated neural tissue was taken
from frog embryos and placed in a drop of lymph. The solution was hung off a
sterile coverslip in a moist environment and cultured for some time. This setup
was actually quite similar to initial methods of hanging drop culture, occurring
much later in the century. Since its inception, almost every step of the cell
culture process has been optimized. Developments include culture containers
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coated with optimal chemicals for cell attachment and synthetic culture mediums
that outperform their blood plasma predecessors. Additionally, new culture
mediums are cheaper, reproducible and antigen free. Antibiotics and antifungal
agents have been developed to mitigate potential contamination sources arising
during normal culture. Small iterations over past decades have improved
culture techniques, while the internet has made vast knowledge bases available
to any research laboratory wishing to join the quest [1].
Traditional methods of culture involve the growth of a cell monolayer in a
flat culture vessel, typically a flask or Petri dish. Culture chambers are made of
plastic and coated with substrates to aid cellular attachment. Cells are grown in
a mixture of culture medium, serum and antibiotics. Other additives such as Lglutamine and insulin may be added depending on the needs of a specific cell
lineage. Additionally, the cell medium may contain phenol red as a pH
indicator. Phenol red transitions from yellow to red between pH values of 6 and
8. The ideal eukaryotic cell's physiological pH is tightly regulated between 7.35
and 7.45. Therefore, fresh culture medium appears red and turns orange-toyellow when acidic metabolites accumulate. Medium must be changed before
the solution becomes fully yellow in color. Cultures are incubated at
physiological temperature of 37ºC for optimal enzyme activity and 5% CO2
saturation to maintain bicarbonate concentration for cell pH buffering systems.
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Once cells reach confluence, they are detached from the culture flask using
trypsin and/or ETDA, and reseeded in a new flask at approximately 10% of the
confluent concentration. This is called sub-culture. It is performed to prevent
cell senescence and nutrient exhaustion. The process of sub-culturing a line of
cells increases its passage number by one. It is important to keep track of the
number of passages as some cell lines lose proliferative and viability capabilities
as well as important morphological characteristics at passage numbers as low as
five [1]. Many cancer cell lines have been immortalized meaning their genes
have been engineered for indefinite proliferation without the loss of viability.
The cells of Henrietta Lacks, who died in 1951, have been around since the 1950s
and are still used today.
The need to create in vitro assays which produce biomedically relevant
information is essential for drug development. 2D cell culture has been
conventionally used for drug candidate testing; however, it has been shown that
the correlation between successful navigation of 2D tests and useful therapies is
limited to none [1]. For this reason, many researchers suggest new
methodologies for screening compounds be developed and tested.
Limitations of 2D culture include the lack of cell-cell and cell-extracellular
matrix (ECM) signaling that occurs ubiquitously in 3D cultures and in vivo. The
ECM is a collection of molecules secreted by living cells which provides
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mechanical support and biochemical influences fundamental to the organization
of tissues. Such signals between neighboring cells and cells-and-ECM are
essential to cell differentiation, proliferation and normal cellular functions [18,
19]. One element lacking in 2D environments important for cell function is
integrin interactions. These integral membrane proteins help link the cells to
their external environment through connections to actin, filamin and other
proteins. Through messenger systems they relay external information and
biochemical cues to the cell. As a result, it has been suggested that 3D in vitro
systems such as MCTS may bridge-the-gap between 2D monolayer models and
expensive in vivo testing [1].
Recent developments in 3D culture technology and analysis have
highlighted potential key differences between 2D and 3D culture. When grown
as monolayers, cells have been shown to have differences in cell morphology,
polarity, receptor expression, oncogene expression, interactions with ECM and
basement membrane, and overall different cellular architectures when compared
to in vivo samples. Confining cells to grow in a 2D space on artificial surfaces
leads to the lack of tissue hierarchy observed in monolayer cultures [4]. Such
findings question the validity and significance of studies performed on 2D
cultures. As a result, the field has shifted towards studying and improving 3D
culture methodologies due to their superior physiological relevance [1].
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Additionally, 3D cultures histologically to represent in vivo microcarcinomas to a
high degree [4]. Figure 1 compares an in vivo tumor with a spheroid (MCTS) side
by side. Notice the many similarities in functional architecture between the two
tissues. One important difference is how they are perfused, the tumor from a
central capillary, the spheroid by culture medium at its periphery.
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Figure 1. Immunohistochemical staining of spheroid sections (b,c,f) next to sections
of biopsied tumor specimens (a,c,e). Reproduced from Kunz-Schughart (2004).

Another reason for the superiority of 3D culture is its ability to preserve
the original phenotype and function of explanted cells. For example, both
primary articular chondrocytes and hepatocytes rapidly lose morphology upon
monolayer culture. In 3D, this loss may be attenuated or even reversed.
Additionally, a study showed how multipotent mesenchymal stromal cell
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(MSC)-derived hepatocytes were better able to perform important functions such
as albumin and urea synthesis, as well as ammonia and drug clearance in 3D [4].
This example is one of many providing evidence for 3D cultures as superior in
vitro models to 2D monolayer culture.
2.4. The Mechanical and Chemical Properties of the In Vitro
Microenvironment and their Influences on Cellular Biochemistry Requirements for Improved 3D Models
The extracellular matrix (ECM) may be thought of as the foundation of
tissues. It is constantly modified by cells to control mechanical and chemical
properties of the microenvironment. Mechanical properties of the ECM are
controlled by the composition, architecture and the degree of crosslinking
between various proteins and biopolymers [7]. Cells are able to finely tune these
properties of local ECM to suit the needs of a specific tissue. Accomplishing this
requires the synthesis, secretion and incorporation of proteins like collagen into
the ECM. Collagen is one protein the cell uses to resist tensional stresses. This
protein, which is actually a heterodimer of interwoven proteins, acts as a
molecular braided rope with a modulus of elasticity between 5 and 11.5 GPa at
room temperature [20].
In order to resist compressional stresses using flexible and soluble organic
molecules, the cell must be more creative. Structural integrity under
compressive loading is accomplished with the use of heavily glycosylated
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proteins called proteoglycans. Glycosylation is the covalent bonding of sugar
molecules to proteins, lipids or other organic molecules. In the case of
proteoglycans, proteins are attached to glycosaminoglycans. They contain many
carbohydrate residues, specifically sulfate and uronic acid groups which are
negatively charged at physiological pH. The result of this negative charge is the
attraction of partially positive hydrogen atoms present in water molecules.
Ultimately, proteoglycans are heavily hydrated molecules which use the
incompressible fluid, water, to resist compressional stresses. The high charge
density of proteoglycans makes protein transport throughout the ECM difficult.
Dynamic compressive forces have been shown to control the deposition patterns
of proteoglycans and protease inhibitors in chondrocytes [21]. This principle has
been exploited in tissue engineering through the mechanical stimulation of
cultures to promote chondrogenesis with good results [22]. Additionally,
basement membrane, secreted basally by epithelial and endothelial cells, also
hinders protein transport and acts to increase mechanical stiffness [23].
Also incorporated into ECM are globular, or nonstructural, proteins which
play important roles as enzymes and in chemical signaling. Globular proteins
control cellular events such as adhesion, migration and ECM remodeling, a
process which occurs constantly in response to the external environment.
Remodeling of the ECM to increase strength is just one example of how

26

mechanical stresses are coupled to chemical composition. Furthermore, globular
proteins help control cell migration, proliferation, apoptosis and differentiation.
The large number of growth factors, chemokines, and other morphogenetic and
signaling proteins secreted and embedded into the ECM during its synthesis
assist cells in accomplishing these tasks. Ultimately, the ECM controls the bulk
and local mechanical environment and contributes to the tissue’s
microenvironment, a microenvironment which is preserved to a much higher
degree in 3D culture compared to 2D.
Production of ECM in spheroids has been described in a number of
studies [24-29] and has been shown to be far more extensive in the amount and
assembly compared to corresponding 2D cultures. Production of ECM in tumor
spheroids is different than in nonmalignant cells. In tumor cells, ECM is
predominantly of tumor cell origin. In vivo, ECM is typically produced by nontumorigenic, stromal cells. In MCTS, this is not the case. Therefore, it is
important to monitor the origin of ECM as this may be a factor in tumor
initiation [26].
2.4.1. Specific effects of external mechanical forces on cellular
physiology. Basal cellular phenotype is determined by integrating the numerous
mechanical and chemical cues strongly coupled in the 3D environment. The
growth and regulation of connective tissues, such as muscle and bone, are

27

strongly influenced by mechanical forces. Mechanical loads are transferred from
the macro to the cellular level where they are transmitted to the ECM and cells
integrated within. This is one example of how molecular signaling mechanisms
are directly coupled to stretch and compression. These mechanisms may be
easily lost in monolayer cultures adhering to a flat, rigid substrate. Molecules
involved include those attached to the ECM, and all types of other extracellular
signaling molecules which respond to the mechanical stimuli: endocrine,
paracrine and autocrine messengers. For example, weight bearing exercises
increase muscle mass and bone density; space travel has the opposing effects.
These are physiological responses to external stresses, or lack thereof.
In addition to eliciting chemical responses, mechanical stresses physically
change the spatial distribution of cells, ECM and effector molecules [7]. This
occurs even in tissues without typical mechanical responsibilities. Many of these
signals are well understood on an individual basis, but the field of tissue
engineering still looks to discover how signals modulate each other to create the
responses observed in vivo. The ECM also binds many growth factors and
biological effector molecules. It further influences the cellular microenvironment
by sequestering molecules which otherwise would diffuse, creating local regions
of higher concentrations. The ECM can also act to slow diffusion of paracrine
and autocrine factors due to its porosity. In this way, the mechanical and
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chemical structure of the ECM directly influences chemical signaling dynamics
[7].
A more complete understanding of the coupling effects between
mechanical forces and chemical signaling will have profound impacts on
regenerative medicine. Additionally, since so many cues are present in the
ECM, recreating this environment in vitro is difficult. Isolating individual factors
and determining unique responses also has limitations due to the variable
composition of ECM between synthetic batches. High-throughput analysis of
multicellular spheroids composed of healthy human cells could be a key model
for future studies on the coupled effects of numerous biological variables.
2.4.2. ECM stiffness and composition regulate cellular response and
phenotype. Matrix stiffness plays a key role in certain cellular processes such as
endothelial organization. During tissue remodeling, morphogenesis, and
differentiation, cells exert stresses on the ECM. Cells can contract the matrix to
varying degrees depending on the number of integrin-ligand bonds and the
architecture of the ECM. Other factors such as cellular migration and
intracellular tension may be affected as well. Stiffer matrix creates increased
difficulty of contraction and greatens energy expenditure. A stiff matrix can
promote endothelial organization while inhibiting other cellular processes [30].
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Two hallmark characteristics of cancer tumors are the lack of ECM
organization and increased matrix stiffness. In cancer, the ECM network is often
deregulated, leading to more malignant cellular phenotypes and metastases. The
elasticity of the matrix is also closely intertwined with its biochemical properties;
a stiff matrix is often an indicator of disease. Since sensing external forces
involves the elasticity of the matrix, the ECM provides mechanical cues that
influence cellular behaviors. The cytoskeleton along with focal adhesion
components, the nuclear matrix, and the nuclear envelope and chromatin act as
the biomechanical sensors that determine how cells react to forces from the ECM
[31]. For example, researchers showed how changes in mechanical forces are
correlated with differences in TGF-β signaling in mouse tendon [32].
Additionally, others showed how increasing the stiffness of mammary epithelia
gels disrupted morphogenesis and enhanced proliferation through a mechanism
of phosphorylation of focal adhesion kinases [33]. Matrix stiffness has also been
shown to play a role in ECM contractions influencing healing and fibrosis [30].
ECM composition and stiffness are important regulators of cellular response.
Swartz and colleagues aimed to show how mechanical stress can be
communicated from stressed to unstressed cells in the coordination of the
cooperative tissue remodeling process [34]. The study showed how mechanical
stress on human airway epithelial cells could elicit a matrix remodeling response
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in unstressed, co-cultured lung fibroblasts through soluble chemical signals. The
results challenge the accepted mechanism of fibrosis in asthma, which has been
attributed to the effects of the inflammatory response. However, it is now
hypothesized that mechanical stresses also play a role in the fibrotic response.
Results of the study concluded that epithelial-fibroblast interactions are complex,
two-way cellular interactions where the presence of each cell type modulates the
response of the other. Additionally, they noted that since the ECM is deformable
and that interactions between it and cells contained are coupled, the
communication which arises due to these mechanical stresses should studied be
more closely. Since fibrosis and ECM stiffness are indicators of cancer, further
studying these communication networks may be important to reveal the
underlying mechanisms of the disease.
Another form of mechanical stress that influences the microarchitecture of
tissues is shear stress from microvascular fluid flows. Microvascular endothelial
cells sense an increased need for fluid flow to a specific region due to higher than
normal shear stresses. Short term responses included increased recruitment of
quiescent capillaries and if the situation persists, angiogenesis may result [35].
In vitro models which contain two or more cell types may respond in
different ways to mechanical forces than single-cell cultures. First, cells may
rebuild their local environment resulting in a new, shared micromechanical
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environment. For example, epithelial cells may stiffen the environment with the
secretion of basement membrane. The rebuilding of the environment may be
coordinated between the signals of the multiple cell types. Secondly, simply the
presence of another cell type may modulate the expression of the other cell types
present [36]. Spheroid co-culture studies have the potential to combine the
power of typical co-culture studies, but in a more natural environment.
Additionally, many cancer pathologies are a result of numerous cell types
present in tumors leading to the observed pathophysiology.
Other molecules present in ECM such as adhesion molecules in the
integrin and cadherin families are critical in determining a cell’s fate with respect
to proliferation, life and death. The apoptotic mechanism is closely related to
contact with other cells, as are mechanisms associated with contact inhibition of
proliferation [29]. An article published in the Oncology Review Editorial in
emphasized the importance of using spheroids as a tool because “such a model
of three-dimensional growth should bring a better understanding of the role of
intercellular adhesion in dictating cellular fate” [29].
2.4.3. Molecular gradients in 3D culture. The composition of ECM and
cells residing within is directly responsible for the accumulation of chemicals
over time. Most gradients, such as oxygen and nutrient gradients, may be
measured and analyzed. For some regulatory molecules such as epidermal
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growth factor (EGF) and other cytokines, concentration gradients are difficult to
measure because good input data is lacking. Work in this area has progressed
due to phenomenological observations in biology that require qualitative
analysis. One important finding is the idea that paracrine loops, once thought to
be a hallmark of cancer, are now understood to be a cells’ probing mechanism
into the local environment. A cell uses autocrine loops to probe the
microenvironment by sending out an array of molecules locally and analyzing
the fraction of the signal returned. It is hypothesized that this aids the cell in
sensing tissue boundaries [37].
Other molecular gradients exist including those of oxygen, glucose and
other nutrients. Tumor spheroids develop significant chemical gradients in
cultures between 200 and 500 μm, with a secondary region of necrosis present in
the center of spheroids greater than 500 μm. It would appear that low levels of
oxygen and glucose present in the central region should be the lead cause of
necrosis, as initially hypothesized. Experimental evidence suggests that these
assumptions may not be true and that the concentration gradient for glucose
itself is rather minimal [38]. However, another hypothesis is that the necrotic
region develops naturally due to force balances and a gradual reduction of cell
density occurring as a result of surface tension and stabilization factors [39].
Regardless, this functional hierarchy of cells closely reflects the in vivo situation
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of actively cycling tumor cells adjacent to capillaries while the inner region of
cells become quiescent and die through apoptosis or necrosis [40], although
quiescence is not a consequence of hypoxia [38]. There is no single, definitive
factor leading to necrosis i.e. hypoxia, lack of nutrients, catabolites or hydronium
ions creating a toxic environment.
One important feature of the spheroid model lies in its ability to
metabolically adapt the central, necrotic cells to maintain intracellular
homeostasis in response to stresses created from gradients [40]. Many features of
cellular physiology are affected by these gradients such as proliferative and
functional features, cellular RNA and protein expression, the distribution and
function of biologically active molecules, and their penetration. All of these
factors lead to response to treatment [4, 40-42].
In order to control the delivery of oxygen and reduce gradients, many
different culture systems have been created. One design includes cell-culture
dishes with a semipermeable membrane. The membrane elevates cells near the
air-medium interface so they may be perfused in a region of higher oxygen
concentration both from above and below. There are also many different
bioreactors including membrane-based, hollow-fiber, rotating drum, and
perfusion bioreactors designed to combat these problems. The pros and cons of
each will be discussed further in section 2.6 3D Culture Techniques and Analytical
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Challenges. However, most of these systems are designed for creating masses of
cells instead of finely controlled and reproducible 3D spheroids such as those
created in this study.
2.4.4. Mechanical and chemical properties unique to spheroids. Just as
in any three dimensional tissue, concentration gradients can exist for any soluble
molecule consumed or produced by a spheroid. The two main competing factors
influencing gradients are diffusion and convection. Both mechanisms affect all
types of molecules, but typically diffusion dominates in smaller molecules, and
convection, or bulk transport, dominates the dispersion of larger biomolecules.
There are two ways established concentration gradients may affect the cell or
tissue. First, cells in different regions of the 3D tissue may behave differently due
to unique conditions experienced by each microenvironment as the result of the
summation of numerous concentration profiles. 3D spheroid cultures therefore
become a convenient way to study the changes along these gradients because of
their spherical geometry. Secondly, gradient dependent cell responses such as
migration may occur which are important for modeling tissue organization and
metastasis [7].
Concentration profiles may be modeled mathematically by Fickian
diffusion. The mass transport equation, governing the relationship, is a balance
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of diffusive transport and tissue consumption. The resulting differential balance
is
,

(Equation 2.1)

where C is the concentration of the molecule in question, x is the distance from
point of interest to the tissue surface, and Q is the volumetric consumption rate
by the tissue. Using zero order consumption,

, the solution

becomes:
,

(Equation 2.2)

where C0 designates surface concentration, L is the distance of diffusion and ɸ is
the Thiele modulus. The Thiele modulus is a dimensionless coefficient which
describes how tissue thickness, cell density (i.e. nutrient consumption rate), and
surface concentration affect the resulting concentration profile as follows:
.
For

, the solution is

(Equation 2.3)

, which means the concentration of the molecule

in question at the surface of the tissue is half of what it was at the source (C0,
L=0). For

, significant concentration profiles develop within the tissue [7].

The most important nutrient gradient to consider is oxygen, as it is rapidly
depleted due to its low solubility in culture medium. It may also be depleted in
areas of high cell density due to large consumption rates. Gradients of glucose
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and amino acids are close to negligible due to their high concentrations and
solubilities [43]. Oxygen gradients affect cells in multiple ways. In addition to
respiration, local oxygen concentrations regulate cellular redox states and affect
signaling pathways. Under high oxygen concentrations, these signaling
pathways may create reactive oxygen species linked directly to DNA damage
[44].
High oxygen concentrations also are toxic to many cells [44]. Significant
oxygen gradients develop in tissues with high cell density and aggregates greater
than 250 μm in diameter. This may occur in aggregates of epithelial cells and
islets behaving normally, but also in various tumor cells. However, in stromal
tissues which are more loosely packed only small, relatively insignificant
gradients occur. Additionally, it should be noted that even in a 2D monolayer
culture, concentrations develop if the medium is unstirred. At a distance just 2
mm under the surface of the culture medium, the oxygen concentration drops
between 50 and 90%, based on the density of culture and consequently the rate of
oxygen consumption. Conversely, low oxygen concentrations may promote the
differentiation of stem cells leading to further changes in the local
microenvironment [45].
pH gradients also play a role in spheroid metabolism and are interrelated
with oxygen gradients. Although, both types of gradients are heterogeneous in

37

shape with respect to the radial axis of the spheroid, there is no direct
relationship between pH and oxygen concentration at the local level. However,
strong correlations were found between mean pH and pO2 profiles [46]. Other
studies looked to find differences between spheroids of various cell lines. It was
found that the quotient of ΔpO2/ΔpH was consistent across all spheroids of a
given cell line. Faster growing spheroids tended to have higher quotients such as
those formed with human colon carcinoma cells (HT29). Low quotient
spheroids, such as those formed with grade IV glioblastoma cells (U-118 MG),
were found to produce about 3 times as much lactate and consume 3 times less
oxygen than HT29 spheroids. This result highlights differences in metabolism
between types of spheroids [47].
One molecule known to create specific engineering challenges in 3D
cultures is protein regulator molecules. Protein regulator molecules have a more
difficult time diffusing through a 3D spheroid culture. For this reason, molecules
such as epidermal growth factor (EGF) are often added to culture media in
concentrations well above their dissociation constant, Kd [mol] [7]. This constant
is a measure of a receptor’s affinity for its ligand and is the concentration
necessary to achieve 50% of receptor binding. Biochemically, this is important as
a strong relationship between ligand concentration, dissociation constant and
biochemical activation is present. EGF binds to epidermal growth factor receptor
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(EGFR) and the complex is internalized, removing the receptor from the
membrane to inside the cell where it can no longer “sense” EGF. Therefore, in
order to achieve a relevant concentration of EGF in the center of a 3D culture, one
must create a higher than normal concentration (>Kd) at the periphery of the
tissue causing many receptors to be bound and internalized. Consequences are
still unclear, but likely outcomes are receptor downregulation and ligand
depletion.
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Figure 2. Spheroid gradient characteristics. The image reproduces a defined 3D
structure and uniform geometry of a spheroid alongside multiple assays showing
molecular gradients present. Reproduced from Hirschhaeuser et al. Multicellular
tumor spheroids: An underestimated tool is catching up again (2010).

2.4.5. Thoughts for the future. Recreating identically the mechanical
properties of the in vivo environment for testing purposes may not be necessary.
In the case of scaffolds for wound-healing and regeneration, the job is simply to
provide support and a reservoir of cells to facilitate natural processes. Often it is
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adequate to create scaffolds with geometries toleranced to tens or hundreds of
microns, and then allow biology to do the rest [7]. In addition to the spatial
distribution of cells on a scaffold, its chemical properties and composition may
be controlled to more closely represent the natural environment.
When engineering the mechanical and chemical environment in a
physiologically relevant way, what amount of precision is necessary? Is it
adequate to simply create some of the structures found in vivo, couple them with
the dominant cues, and to allow biology to do the rest? For example, cells secrete
their own ECM and growth factors to impact and control tissue synthesis and
organization. The tissue engineering in vitro model may only need to produce an
environment suitable enough for deposited cells to take over and turn the
artificial niche into a more natural one for studying biology. In this way, the
power of biology is used for its own study. Only time and further research in
tissue engineering and regenerative medicine may fully answer these questions.
2.5. Why 3D Culture?
“Keeping in mind the fundamental differences between monolayers and
spheroids with regard to cellular sensitivity to various treatment modalities,
tumor spheroids should be mandatory models in applied cancer research, for
example in major programs for drug screening and development” [29]. Two
dimensional monolayer culture appears to be an adequate environment for a
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very select few number of cell types accustomed to growing as multilayered
sheets in vivo. Although, even in this scenario, cellular adherence to artificial
substrates fails to reproduce the native environment. A true basement
membrane, along with vasculature, is lacking. For example, epithelial cells such
as keratinocytes and corneal epithelial cells may be adequately modeled in vitro
in this manner [48]. Almost all other cell types should benefit from a culture and
study in a more realistic environment.
Scientists have long understood how removing cells from the in vivo
environment changes many important variables while also inducing atypical
conditions. Even though the cell is the most fundamental repeating structure in
biology, the functional unit of tissue is recognized as cells plus ECM [19].
Unique properties emerge from the synergistic effects of cells interacting with the
ECM to form tissues, as discussed in 2.4. For this reason, improving drug
development requires studying the effect of compounds on tissues as a system, a
methodology proven to be more indicative of the in vivo response. Properties
such as specialized cell-cell contacts, polarized morphology and attachment to
underlying basement membrane help comprise the normal functions of a tissue.
These functions are essential for proliferation, differentiation, survival and
secretion, and may aid in drug resistance [49]. The goal of 3D culture is to
produce the most in vivo-like structures possible to more accurately predict drug
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response. By including 3D culture into the drug development process, this
technique can bridge-the-gap between simplistic in vitro 2D analysis and more
complex animal models of disease. Implications include rapidly increasing the
speed of drug screening to potentially save large sums of money, and the ability
to create more effective, less toxic therapeutic regimens [1].
Experts in cell biology believe that 3D culture is a basic necessity for the
development of therapeutics, a natural stepping stone before turning to wholeanimal studies [4]. Unfortunately, the use of rodent models is driven not by
predictive capacity and scientific reasoning, but by regulatory and legal
requirements, as well as strong clinical tradition. By maintaining a large number
of rodent models, the overall predictive power is increased. No single model has
substantial predictive power alone. Since the cost of drug development increases
significantly at the rodent model stage, screening out poor candidates with cellbased models early in the process has been a long-standing strategy. Improving
the power and capacity of these cell-based models to eliminate toxic and
nonfunctional compounds could effectively streamline the entire process. Cellbased approaches will remain an important part of the process as they are low
cost, take less time and use intact cells as a good representation of living patients.
Cell-based approaches are important because they capture responses not
observed in rodent models. Multicellular tumor spheroid cultures are an ideal
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testing platform of intermediate complexity, fitting logically between monolayer
culture and in vivo animal systems.
Testing potential drug candidates should involve the most natural in vivo
representation possible with respect to the spatial arrangement between cells and
ECM, the resulting interactions, and other biological factors which influence the
microenvironment. Three dimensional culture techniques have been used by the
biomedical community in studying organogenesis and tumor progression since
the first half of the 20th century. Today, it is well known that 3D culture is
highly superior because it can restore biochemical and morphological features
lost through 2D monolayer and suspension techniques. Unfortunately, the full
potential of 3D culture has been ignored until recently. Supporting research in
3D culture technology, the National Cancer Institute has developed a program
called Signatures of the Cancer Cell and its Microenvironment. It awards $40
million per year for research aiming to increase understanding of the relationship
between microenvironment and tumor pathology. During this program, 3D
culture will be emphasized in hopes of making its use more widespread in the
scientific community [4]. Seemingly, it does not make sense to study organs and
tissues using a homogenous cell population as is often employed in 2D culture.
3D tissues do a better job of mimicking the complex structures and relationships
of vessels, nerves and stroma, and can do so while incorporating the numerous
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cell types present to the in vivo situation which are known to modulate each
other.
2.5.1. Elucidation power of spheroids through biological mechanisms.
Spheroids are widely used in biology for their ability to provide a 3D in vitro
model to study proliferation, death, differentiation and metabolism of tumor
cells in response to radiotherapy or chemotherapy. It is also believed that
including spheroids in high-throughput analyses during the drug delivery
pipeline could greatly expedite the process of developing new therapeutics.
Generating spheroids takes 24-48 hours, potentially longer depending on cell
line, and creates cultures with homogeneous sizes, morphologies, and a specific
regionally based pattern of cells. This pattern includes cells at different points in
the cell cycle with regards to growth and arrest. It consists of a stratification of
proliferating cells at the rim of the spheroid, and hypoxic, necrotic cells in the
core of the tissue, with a region in between of quiescent cells [50]. These
differential cell cycle states are also realized when observing in vivo tumor
pathology.
However, most cell types require cues from an environment that is similar
enough to the native 3D arrangement in order to respond in a physiologically
relevant way. Adding a third dimension to cell culture allows cells to receive
external mechanical inputs for cell adhesion and attachment in all planes. This
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affects integrin ligation, cell contraction and intracellular signaling, all of which
are important to the life of a tissue and rooted in the ECM [51]. Spheroids make
a great tool for probing cell-cell and cell-matrix interactions through tissue-based
mechanistic assays because they replicate a specific cellular niche. They have
assisted the investigations of biologists in elucidating the roles played by
adhesion molecules in tumor pathology [52].
The third dimension also allows chemical signals to affect the cell in a
more natural way. For instance, the 3D matrix binds important molecules such
as growth factors and enzymes. Normally in a tissue, these molecules occur in
gradients which may not be present in 2D, eliciting specific cellular responses.
Evidence has also shown that the 3D environment may be necessary to study
remodeling events, such as epithelial acinar duct formation, occurring over
longer-length time scales [19].
Just like with nutrients such as oxygen, treating cultures with a
chemotherapeutic drug creates a concentration gradient between the central and
peripheral regions of the spheroid [53]. In vivo tumors develop similar gradients
due to poor drug uptake by the tumor or poor distribution within the tumor.
The rate of diffusion into tumors is a clinically significant factor with respect to
the efficacy of treatment [54]. As a result, basic pharmacokinetic features should
be replicated in cell-based assays for optimal relevance.
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Spheroids have also been used as a tool to investigate cell-matrix
interactions. Spheroids have played an important role in investigating a new
immune-activation phenomenon called nemosis. Nemosis is programmed cell
death in activated fibroblast spheroids without the normal apoptotic markers,
but accompanied by the production of cyclooxygenase (COX) 2, proteinases and
proinflammatory cyto- and chemokines [55]. Knockout studies, or those
blocking fibronectin receptors, have shown that nemosis is initiated by integrinfibronectin binding and regulates fibrocyte spheroid formation [52].
Other novel proteins, such as the gap junction proteins connexins and
pannexins, have been studied using spheroids. Spheroid studies using the C6
glioma cell line have shown the ratio of Panx1 to Panx2 proteins determines the
degree of packing of cell aggregates. In addition to recapitulating cell-cell
interactions, spheroids also better represent morphogenetic movements such as
tissue contraction and condensation [52].
2.5.2. Mechanism of drug action and culture environment have
profound effect on resulting therapeutic capacity of drugs. There is a
difference in resistance to apoptosis and chemotherapeutic drugs with spheroid
cultures compared to monolayer cultures. This fact supports the hypothesis that
differences in culture environment can affect how cells respond to drug
treatments [1]. One specific study by Tung et al. [56] highlights how drug
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mechanism of action and the culture environment can have a profound effect on
drug efficacy, and thus the resulting viability of remaining cultures. In the first
study, 5-fluorouracil (5-FU) was applied to both 2D and 3D culture at the same
concentration of 10 μM. 5-FU is a thymidylate synthase inhibitor which blocks
the synthesis of pyrimidine and thymidine necessary for DNA replication. The
overall effect is a reduction in cell proliferation. The drug reduced 2D cultures to
only 5% viability after 96-hours of treatment while 3D cultures remained at 75%
viability after identical treatment. It was concluded that the 3D spheroids were
better able to resist the anti-proliferative effects of the 5-FU through multicellular
tumor resistance. Multicellular tumor resistance reflects the intrinsic drugresistant phenotype of most solid tumors, and it is the ability for a cluster of cells
to better resist therapeutic attempts through limited drug penetration and a
reduced number of proliferating cells as drug targets. Almost all conventional
cytotoxic anticancer drugs are less effective at killing MTSC than monolayers of
tumor cells [9].
Tirapazamine (TPZ), a hypoxia activated cytotoxin, was tested in an
identical manner. In 2D culture, cell viability was reduced to 72% after 96-hours
while in corresponding 3D cultures, viability was reduced to 40%. The opposite
effect compared to 5-FU was observed as 2D cultures were more resistant to the
drug. Since 3D spheroids generally have hypoxic cores due to limited oxygen
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diffusion, the finding of increased therapeutic efficacy in spheroid culture
supports the mechanism of action. Up to 60% of in vivo solid tumors have
hypoxic regions within their structure, further supporting the use 3D spheroid
models as testing platforms in drug development, and showing how this region
can be used as a drug target. The study highlights how culture methods can
drastically alter the effect of a drug on cells. It also shows that 3D cultures are
not necessarily more resistant to all drugs, and drug resistance is a combination
of the specific drug and the cellular environment where its effects take place [56].
Furthermore, the study highlights how a potential drug candidate may be
screened out early in the development process if only tested in 2D, thus
emphasizing the importance of testing drugs in the more realistic 3D
environment.
Differences between 2D and 3D culture were noted in SKBR-3 cells which
overexpress the oncogene HER2 [57]. Cells grown as spheroids using the forcedfloating p-HEMA-coated plate method had HER2 homodimers form [58]. In 2D
culture, the same cells formed HER2 heterodimers with HER3.

Further

differences in 3D culture included reduced epidermal growth factor receptor
(EGFR); enhanced phosphorylation of HER2, HER3 and EGFR; and the
downregulation of activated protein kinase B, an important protein in
metabolism, apoptosis, proliferation, transcription and migration. Additionally,
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it was shown that trastuzumab has a significantly differing effect on cells grown
in 2D versus 3D. Trastuzumab is a monoclonal antibody used to treat breast
cancer which binds the overexpressed HER2 receptor. The drug leads to cell
arrest during the G1 phase of mitosis and reduces cell proliferation. The study
showed that proliferation was reduced by 48% in spheroids but only 16% in
monolayer culture, suggesting differences in signaling patterns between the two
tissue architectures, specifically, altered phosphoinositide 3-kinase (PI3K) and
mitogen-activated protein kinase (MAPK) signaling [40].
Further examples of differing results in 2D versus 3D have been noted. Li
et al. showed that MCF10A cells (fibrocystic, non-malignant breast cells) cultured
in 3D exhibited a higher resistance to doxorubicin, a drug which inhibits the
unwinding of DNA for transcription, compared to those grown in 2D. Cell lines
SA87 (brain derived, metastatic breast cancer), NCI-H460 (large cell lung cancer)
and H460M (metastatically derived from pleural effusion, large cell lung cancer)
grown in 3D all have higher resistance to 5-FU and doxorubicin than those in 2D
[59]. Finally, 3D cultured MCF-7 cells (breast cancer) treated with tamoxifen are
more viable than those grown in 2D and treated with the same drug
concentrations [60].
Culture environment also strongly influences the resulting cellular
physiology. One study showed that culturing breast-epithelial cells on ECM
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restored some mammary-specific gene expression not observed during culture
on standard polystyrene plates [33]. Another study [19] showed how the
organization of the microenvironment could contribute to different cellular
responses due to the same biological factor. In the study, both non-malignant
and malignant HMT-3522 breast cells were grown in 3D using Matrigel. The
non-malignant cells organized normally, forming polarized acini as observed in
vivo. The cancerous cells formed disorganized, loose aggregates. Both
populations were then treated with antibodies against β-integrin, an
overexpressed surface receptor in the malignant cells. β-integrin caused
apoptosis in the healthy cells; however, it caused an apparent reversal of
phenotype in the cancerous cells back to the normal cell type. This occurred to
the point that the two cell populations became indistinguishable. The
experiment was repeated in 2D and this result was not observed. This showed
how extracellular cues can affect cellular phenotype. It was hypothesized that
cellular phenotype was dominant over genotype in this situation [18].
2.5.3. Additional applications of MCTS cultures. Spheroids are often
spoken of in terms of developing cancer therapeutic drugs; however, the
technology is applicable to other disease states and treatment modalities.
Spheroids have been employed as models for a myriad of other therapeutic
techniques including radiotherapy, chemotherapy, radioimmunotherapy, cell-
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and antibody-based immunotherapy, hyperthermia, gene therapy, and
photodynamic treatment. Additionally, MTSC have been routinely employed in
studies regarding the microenvironmental regulation of proliferation, viability,
energy metabolism, nutrient metabolism, invasion, cell-cell interactions, and
ECM composition [61].
Further uses for spheroids include the investigation of specific host-tumor
cell interactions including evasion as well as evaluations of normal cell injury
due to tumor cell presence. A technique used to study this involves growing
spheroids and placing them on monolayers of confluent fibroblasts or
endothelial cells with an underlying ECM. Conversely, fibroblast spheroids may
be cultured in tumor cell suspensions to study tumor cell invasion/migration.
This technique also allows for the study of tumor cells which do not form
spheroids on their own. Incubating tumor or stromal spheroids with immune
cell suspensions likewise allows the study of immunological response in vitro
such as migration, differentiation and activation. These co-culture systems have
been employed to study the interactions between cancer cells and their cellular
environment, and have the potential to be applied to study simplified versions of
any biological system. It may be ideal to use these advanced types of systems to
gain a fuller understanding of drug sensitivity as well as to screen for agents that
affect the host-tumor interaction.
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2.5.4. The rationale for MCTS in HTS approaches. While generating and
maintaining 3D cultures may be more labor-intensive than 2D, the tradeoff is
that incorporating spheroids into in vitro drug efficacy and toxicity testing will
probably yield more accurate versus monolayer culture alone. 3D culture will
allow the more rapid selection of lead compounds worth pursuing [1].
The rationale for using spheroids can be lumped into four specific points.
The first is that spheroids recreate the morphological, functional and mass
transport phenomena of similar tissues in vivo. Specifically, cells in spheroids
restore the observed in vivo differentiation pattern for several weeks of culture.
This recapitulation of in vivo function is not only relevant for modeling the
pathophysiology, but also is useful for studying penetration, binding, and
bioactivity of drugs. The morphology of spheroids is close to that of
experimental tumors in mice and natural tumors in humans, before
neovascularization occurs [3].
Secondly, MCTS approximate the growth kinetics and microenvironment
of avascular tumor nodules, micrometastases and intervascular regions of large
solid tumors. The Gompertz equation is used to predict tumor growth in vivo [4].
It has been shown, along with multiple other biologically based mathematical
models, to analogously predict spheroid growth in vitro. MCTS exhibit two to
three distinct morphologies, depending on the diameter of the culture. A
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proliferation gradient is observed which begins with a layer of proliferating cells
at the periphery, a layer of cell-cycle-arrested cells stuck in the G0 phase in the
middle, and in cultures larger than 400-500 μm a hypoxic, necrotic core. As
previously discussed, oxygen and nutrient gradients develop inward, while
catabolite gradients outward, just as observed in tumors in vivo. These play
important roles in how tumors respond to drugs.
The third benefit of using spheroids is that their spherical symmetry
allows for a direct comparison between structure and function. Specifically,
microenvironmental gradients, biomarkers and cell morphologies can be
spatially correlated to changes in cellular physiology. There are three ways that
this can be very useful. The first advantage is that assays can be directly related
to a specific region of the spheroid either through in situ histological analysis or
by harvesting cell subpopulations for further analysis. Additionally, the
spherical symmetry allows for simplistic, theoretical predictions to radiation
response, drug penetration and binding, or the interpretation of typical studies
such as cell viability and proliferation. The third advantage is the ability to
create large groups of individual, identical cultures as long as a homogenous cell
population is used with constant external culture conditions [4].
Finally, spheroid culture can be adapted to allow for the coculture of
multiple types of cells. Of most interest is the coculture of cancer cells along with
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one or more noncancerous stromal cell types such as fibroblasts, endothelial cells
or hematopoietic cells. Co-culture systems have not been extensively
characterized but have the potential to be even more relevant than single-cell-line
systems. Understanding the relationship between healthy and cancerous cell
populations is necessary in the study of disease progression, as these
relationships play important roles in tumor pathology.
The chief scientific officer of a major pharmaceutical company was quoted
saying, “In 10 years, anyone trying to use 2D analyses to get relevant and novel
biological information will find it difficult to get funded.” A paper published in
Critical Reviews of Oncology in 2000 stated, “Notably, spheroids seem to be the
appropriate model to study novel hypoxic markers, targeted therapy,
multicellular mediated drug resistance, and heavy ion irradiation” [3].
Researchers and academics at the precipice of new technology have been waiting
patiently for this technology to become widely adopted, and now is finally the
time where we are beginning to see such shifts in biomedical research take place.
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2.6. Three Dimensional Culture Techniques
MCTS were originally adapted to cancer diagnostics in the early 1970s by
Sutherland and associates [62]. This model is still used throughout research labs
and has the most potential for application to HTS systems in anticancer drug
development. MCTS have greatly contributed to our knowledge of cellular
response and, possibly more profoundly, have allowed researchers to
understand the “microenvironmental regulation of tumor cell physiology” [63].
Initial methodologies for generating spheroids involved placing a drop of cell
suspension on the lid of a standard Petri dish and then inverting it. The lid, with
up to a few individual drops, was placed back on the dish containing a liquid
such as media or PBS to keep the environment humid during culture. Since the
1970s, methodologies have rapidly improved alongside developments in
electronics and control systems, micro manufacturing, and chemical engineering.
2.6.1. Forced-floating methods. Spheroid formation may be induced by
preventing a solution of cells from attaching to the culture vessel surface leading
to self-adherence. Forced-floating methods prevent this by modifying the
surface, thus promoting cell-cell contacts and spheroid organization [64]. Some
coatings used to prevent attachment include 0.5% poly-2-hydroxyethyl
methacrylate (poly-HEMA) and 1.5% agarose. The benefits of this method are
reproducibility, uniform spheroid size as a result of identical initial cell

56

concentrations, compatibility with high-throughput testing, and the ability for
long-term culture. However, some drawbacks include the time it takes to coat
the plates, costs of purchasing pre-coated plates, and difficulties with media
changes [42, 50, 65].
2.6.2. Agitation-based approaches. There are two main types of agitationbased approaches: (i) spinner flask bioreactors [65, 66] and (ii) rotational culture
systems [67]. Both systems involve placing a cell suspension in a large vessel
which is kept in motion through stirring or rotation of the vessel walls. In this
way, cells do not adhere to the vessel walls, but come together through cell-cell
interactions [68].
Spinner flask bioreactors are employed as a simple technique which can
create many spheroids very rapidly. This technique excels in long-term growth
of cultures requiring media changes. The motion of the flask is also thought to
aid in mass transport of nutrients and wastes. One particular drawback of this
culture technique includes the exertion of shear forces on aggregates due to
constant stirring. This may elicit mechanochemical responses and affect the
natural physiology of the cells. Additionally, spinner flasks use large amounts of
media and produce a broad range of spheroid sizes requiring the difficult task of
sorting the resulting tissues for drug screening assays [64]. To combat this issue,
spheroids may be initially formed using a forced floating or hanging drop
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technique and then placed in the spinner flask for long term culture [69]. This
method ensures a more uniform spheroid size and allows for environmental
control over nutrient and oxygen exchange during extended culture. However,
the spheroids still must be replated into 96- or 384-well plates for assay, creating
many extra steps in the process.
Instead of using a stirring mechanism, rotating cell culture bioreactors
function by rotating the culture container itself. These were initially developed
by NASA in 1992 to mimic microgravity and exert low shear forces in culture.
The culture chamber, which screws onto a rotator, is slowly rotated along its
horizontal axis. The result is the ability to keep cultures in the center of the
vessel, preventing attachment to walls. Low shear forces are the main advantage
of this system. The speed of rotation can be increased over time as spheroids
become larger and fall through the medium faster. Further advantages and
limitations are the same as in spinner flask bioreactors; rotating bioreactors use
simple methods, enable the production of a large number of spheroids, and
allow for long-term culture with easy media changes with little ability to control
the size of spheroids generated.
2.6.3. Microfluidic cell culture platforms. Most microfluidic culture
systems only support 2D culture which is arguably no longer relevant [70].
However, some researchers described a system allowing 3D culture with
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collagen-matrix interactions and imaging in three spatial dimensions. The
system works by passing a cell suspension through an array of micropillars.
Cells aggregate inside the pillars and the spheroids are perfused by the passing
culture medium. Once a certain level of 3D structure is achieved, collagen is
passed through the system fixing the cell structures and allowing for cell-matrix
interactions [71]. The benefits of this system include the ability to work with
high-throughput testing, high content analysis due to imaging capabilities, and
minimizing reagent volume. Limitations of the system include the lack of
opportunity to retrieve and extensively characterize the spheroids formed [71].
Other similar systems like this exist and may ultimately challenge currently
employed systems as they allow for a finer degree of control over nutrient and
drug administration while allowing for imaging without intermediate steps.
2.6.4. Matrices, scaffolds and the tumor fragment model. Since cells
naturally interact with ECM in vivo, it stands to reason that 3D culturing methods
allowing cell-ECM interactions would better reproduce the natural cellular
environment. Matrigel is a commercially available ECM derived from
Engelbreth-Holm-Swarm (EHS) mouse tumor cell basement membrane proteins.
EHS is composed of collagen IV, laminin, perlecan, entactin, matrix
metalloproteinase-2 and growth factors [72]. Cells growing in ECM interact with
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each other in a natural, three dimensional way and develop similar structures to
those observed in vivo.
There are two notable ways to apply extracted ECM into the generation of
spheroid cultures. The first method involves incorporating ECM into a gel and
embedding the cells within the gel for growth. The second method involves
creating a similar gel, but instead growing the cells on top of it after
micropatterning the surface of the gel with an array of shallow wells [73].
Although generating spheroids in this manner does take comparatively more
work, it is still relatively easy and thus commonly employed. Some additional
drawbacks include differences in composition between batches of ECM, costs of
purchasing the ECM itself, non-uniform spheroid sizes generated, and the fact
that the spheroids end up unevenly distributed throughout the ECM if grown
within. The micropatterning technique works to alleviate this problem by
creating spheroids at specified locations [74].
Biodegradable materials such as collagen, laminin and alginate may be
fabricated into scaffolds with optimal chemistries and geometries for cell growth
and metabolism. Engineering scaffolds is a hybrid field of chemical and tissue
engineering. Cells seeded onto scaffolds may migrate between fibers, attach to
fibers, and form 3D cellular structures in the interstitial spaces between fibers
[75]. These materials may be designed to incorporate ECM molecules that can be
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released to the cells over the degradation life of the scaffold, creating in vivo-like
cues [76]. The most important parameter to control is the scaffold’s porosity as it
dictates cellular attachment and mass transfer properties [77, 78]. Ultimately, the
scaffold facilitates the growth of the cells into 3D structures which resemble the
geometry of the scaffold after it has degraded and been eliminated . Therefore,
scaffolds are not typically used to make spheroids, but other three-dimensional
shapes.
The tumor fragment spheroid model involves mechanically dissociating
tumor specimens and using the resulting fragments to generate spheroids. The
cellular components of the resulting fragment spheroids often vary greatly.
Some spheroids may contain predominantly tumor cells while others are
comprised of a majority of stromal elements (i.e. fibroblasts, pericytes, etc.) [79].
2.6.5. Hanging drop method. The hanging drop method uses a small
aliquot (40 μL for the Insphero system) of cell suspension pipetted into 96
bottomless wells in a three-part culture plate. The wells allow the droplets to
attach via surface tension and hang from the central of the three plates (Figure 3).
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Figure 3. Spheroid formation in hanging drop plate (3D biomatrix
https://3dbiomatrix.com/features/)

The cells eventually collect and form a dense, tightly-packed spheroid in
the bottom of the droplet near the air-liquid interface. If allowed to culture for
long enough, the cells may even proliferate after forming a spheroid. Droplets
are kept moist by an absorbent pad hydrated with sterile water housed in the
bottom part of the plate. The third piece is a top plate, covering the apparatus
and keeping the system moist. The InSphero Gravity-PLUS system may then be
wrapped in parafilm to further prevent droplet evaporation. In addition to
losing water, droplet evaporation creates a dangerous hypertonic environment
for the cells. The InSphero system also comes with a non-adhesive GravityTRAP plate used to transfer spheroids from hanging drop to standard 96-well
culture. This plate allows for further cultures or assays to be performed.
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Hanging drop culture is relatively simple and has been reported to
generate uniform spheroids at a rate close to 100% for many different cell lines.
Further benefits of the system include easy media changes and uniform 3D
tissues with low variability in sizes. Klem et al [80] reported that the tissues
created were patho- and physiologically relevant because spheroids created their
own ECM and displayed high levels of tissue organization characterized through
histology. The major drawback of this technology is the droplet size is limited to
approximately 50 μL and creating tissues larger than 1000 μm in diameter proves
difficult.
2.6.6. Limitations of spheroids. One limit of spheroids is the time
necessary to expand cells, form spheroids, and have them grow to sufficient size
to develop the three typical morphological regions as observed in vivo.
Typically, it takes 2 to 4 weeks for an aggregation of a few cells to reach the point
of usefulness. This process may be expedited by forcing a large number of cells
to aggregate; however, this technique will still require a few days to one week for
proliferative and viability gradients to develop. There are many ways available
that can expedite this process including 3D culturing with other reagents such as
methylcellulose and collagen. This has reduced spheroid formation from one
week to as low as two days in our lab. However, the exact roles of these
components are unknown. One paper reported that collagen and agarose
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networks may reduce natural cellular motility through steric forces in spheroid
models, but this occurred with increased agarose concentration, not collagen
concentration alone [81]. Fortunately, time to complete assays on 3D cultures
would be similar to assays involving monolayers as the screening of drugs can be
done once spheroids are formed. It would appear that the limitation of added
setup time would be outweighed significantly by superior and more relevant
resulting information. Another limitation of spheroids is the lack of
standardized, well characterized tumor models for use in conducting studies.
Finally, the 3D spheroid model will never replace animal testing in the
drug-development process. Even though tumor, and even normal cell models
made with spheroids provide a myriad of new information, the system lacks the
complexity necessary for complete study and understanding of absorption,
distribution, metabolism, elimination and toxicity [4]. The use of 3D models for
studying toxicity of potential compounds is speculative and there is no current
way to extrapolate data from spheroids to in vivo systems; animal testing is not
going away. Microfluidic devices which incorporate and link spheroids and
other three dimensional tissues made from cells of different organs may help to
elucidate the relationships between such organs that are not possible in today’s
3D culture.
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2.7. Analytical Challenges of Spheroids
A major reason that promising 3D culture systems used in basic and
applied tumor biology are not used for drug screening and other HTS systems is
the lack of simple, controlled techniques for rapid, standardized assays. The
current trend in 3D culture technology has emphasized increasing the
throughput of simple culture systems without regard for in vivo relevance of the
resulting cultures or their ability to be easily analyzed. Increasing throughput
without regard to the resulting in vitro biological data recreates flawed logic in a
similar way that monolayer culture hoped to replicate the in vivo environment.
Analytical protocols for high-throughput analysis of 2D cell-based screens
are well-established and documented. Unfortunately, translating methods
directly to 3D setups is not straightforward as new analytical challenges are
created in these systems [52]. For example, in the lactate dehydrogenase (LDH)
cell viability assay, the volume of culture causes a linger in fluorescent signal
making the data unreliable [82]. Additionally, the necrotic core of 3D cultures
naturally creates an increase in lactate dehydrogenase enzyme which is not
necessarily indicative of the viability of cultures. Analyses such as screening for
cell viability and spheroid size can be done using automated processes. But
beyond screening for clinically relevant drugs, limitations are encountered when
testing for drug toxicity as drug penetration, contact-dependent multidrug
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resistance, and oxygen deficiency create difficulties with the cultures themselves.
These are the mechanisms we hope to capture with HTS 3D spheroid histological
analysis. Furthermore, mechanistic assays which explain differences between 2D
and 3D are not readily available, and the ones that work in 2D do not always
work when analyzing 3D cultures. For example, researchers had difficulty
determining the therapeutic range of irinotecan, a new anticancer drug, on
colorectal cancer spheroids because the proper assays were not available [42].
Others hypothesized that showing increased osteogenic properties of human
MSC/HUVEC spheroid cocultures would not be possible with current assay
technology [52]. As previously mentioned, controlling spheroid size, and
therefore the presence of hypoxia in the core, can create additional variables
which become essential parts of the assay. In addition to researching 3D culture
methodologies, the field must tune the respective 2D assays into the third
dimension to make the technology truly useful for drug development.
Confocal microscopy is a technique that can be successfully applied to
imaging spheroids. Its benefits include imaging spheroids up to 320 μm in depth
and the ability to apply live/dead and some other fluorescent stains [83]. As
early as 1995, the potential for imaging spheroids was realized, and the ability to
image and separate spheroids based on the three standard regions of
proliferation around the rim, quiescence in the center, and necrotic cells in the
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core was described [84]. The work showed how cells begin developing a necrotic
core around 400 +/- 25 μm in size. However, this technique is not as easily as
applicable to HTS as the different layers of cells may pose an analytical challenge
as the structures interfere with chemiluminescent signals. Confocal microscopy
is also tedious and expensive with a single unit costing over $500,000, and more
if customized to suit HTS analysis. Therefore, this technology is not available in
many standard biology research labs. Other researchers are currently
developing confocal microscopy methods for rapidly measuring drug
penetration into individual spheroids with optimism that the technique may be
applied to HTS technologies [4]. This type of assay would show which
compounds to have the ability to penetrate a tumor-like tissue.
Finally, should data be successfully collected in a HTS set up, such a large
amount of information will require new dedicated systems for processing and
analysis. Fenema et al. reported in 2013 that “to the best of our knowledge, highthroughput confocal structural analysis of 3D cultures has not yet been
established” [52]. Some assays that have been reported to work include gene and
protein analysis using multiplex PCR and multiplex ELISAs, respectively. Thus,
the paramount future challenges of spheroid HTS are assay development and
analysis of large quantities of data.
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Many assays that are currently used for 2D cultures could be easily
adapted to 3D, such as those used for cytotoxicity, proliferation, drug binding,
apoptosis, and ATP level [4]. However, the response would be an average of all
cells in the aggregate and information on differential, regionally based responses
would be lost. Standard phase-contrast microscopy in conjunction with
computer image analysis could be used to acquire such information such as the
growth and shrinkage of spheroids. Furthermore, commercial automated
microscopy systems could be fitted to rapidly analyze the effects of drugs on
spheroid growth. Again, these techniques would unfortunately sacrifice many of
the advantages of the 3D spheroid model.
The creation of new methods to stain individual, intact spheroids and
measure the extent of necrosis should be simple and straightforward from a
histological perspective, but using common methods would be time consuming
and inefficient due to processing only a handful of spheroids at a time. This data
would provide information on the effects of drugs on the viability of the inner
cells of the spheroid. Furthermore, other stains may be applied to measure
apoptosis, proliferation and various metabolic markers that could be read by an
image-screening system applicable to HTS format. Additionally, assays to
measure differing responses of subpopulations of cells (proliferating, quiescent,
hypoxic) would significantly enhance the usefulness of MCTS [85].
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MCTS may allow in vitro assays for penetration and binding of drugs in
the 3D format. Assays done on monolayer cultures that were difficult to adapt to
HTS, may now be performed in HTS format. By monitoring drug binding in
individual tumor and host spheroids, a system may be developed to measure the
differing binding properties of new compounds. Dosing spheroids at different
times would allow for the kinetic analysis of drugs and even the calculation of
their effective diffusion coefficients [4].
Horman et al showed how entire plates of spheroids could be quantified
by optical imaging for rapid, multicolor, whole-well quantification. However, it
still remains to be seen how spheroids can be analyzed through histology in
high-throughput manners [86].
A recent method for toxicological and biomedical testing uses a
bioelectrical microarray system to calculate the impedance of in vitro tissues.
This method may be applicable to spheroid culture providing information on the
drug activity in the spheroids. Unfortunately this test would calculate the
average effect on the population of cells in the spheroid, losing any regionally
based differential responses [87]. Regionally based information is the main
advantage of sectioning and staining spheroids in a microarray system.
Clearly advancements in assay technology are necessary to bring spheroid
systems into the HTS arena. Investing in these technologies should be seen as
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worthwhile as there are clear advantages to HTS spheroid systems. Screening
protocols for measuring cytotoxicity, growth arrest and viability could be
developed rather simply and applied to high-throughput systems. Assays that
work in homogenous cell population spheroids would also be applicable to coculture systems [4].
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Chapter 3
Methodology for the Creation of a 96-Spheroid Microarray for HighThroughput Analysis
3.1. Microarray Mold Creation
A positive, aluminum mold was designed in SolidWorks™ (Figure 4) and
machined using a 5º, 1/32” tapered end mill (Ford) via a computer numeric
controlled (CNC) process. An end mill with 5º tapers was selected in order to
provide relief during mold release. The aluminum part was used to create a
polydimethylsiloxane (PDMS) negative mold along with the Slygard ® 184
Silicone Elastomer Kit. A 10:1 base to curing agent ratio was used per the kit’s
instruction manual. This mixture was poured over the positive mold into a Petri
dish and allowed to cure in the oven at 65ºC for a period of 24 hours. Figure 4a is
a three view drawing of the positive mold. Figure 4b shows the final PDMS
negative mold created from the aluminum part.
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Figure 4. Microarray PDMS mold fabrication. (a) Three-view CAD drawing of
negative mold in millimeters (left). (b) Final PDMS mold to be used in microarray
formation (right).

3.2. Culture of HTB-126 Breast Cancer Spheroids
Breast cancer cell line Hs 578T (ATCC HTB-126™) was cultured with the
®

following media: Dulbecco’s Modified Eagle’s Medium (Gibco) supplemented
with 10% fetal bovine serum (Gibco), 1% Penicillin-Streptomycin (Gibco), and
0.01 mg/mL insulin isolated from bovine pancreas (Sigma-Aldrich). Cells were
incubated at 37ºC with 5% CO2 and grown in 75 cm2 adherent bottom culture
flasks (Sarstedt) until confluence. Media changes were made every other day.
Cell harvesting began with aspiration of the entire culture medium volume
followed by the addition of 5 mL of 0.25% Trypsin-ETDA (Gibco) which was
incubated for 5 minutes at standard cell growth conditions. The trypsinized cell
solution was collected, combined with 5 mL of fresh culture media, and
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centrifuged at 1500 rpm for 5 min. The supernatant was discarded and the cell
pellet was washed twice with 1 mL fresh culture media. Breast cancer cells were
resuspended in fresh media supplemented with 0.24% methylcellulose prepared
as described in [88] and seeded at densities of 20,000 to 35,000 cells/spheroid
using the GravityPLUS™ hanging drop system (InSphero). Cell densities were
verified using manual hemocytometry (Hausser Scientific). The densities are
equivalent to cell concentrations of 5.00 x 105 to 8.75 x 105 cells/mL for 40 μL
drops. The cell suspension was allowed a period of 3 days for 3D spheroid
formation with one media change after 48 hours. Culture plates were wrapped
in parafilm to prevent media evaporation. Additionally, 15 mL deionized water
was added to the bottom chamber of the GravityPLUS™ system along with the
humidifying pad provided by Insphero. To change the media, a 12-channel
multipipettor (Fisherbrand Elite) was used. 15 μm of media was removed,
discarded, and replaced with 17 μm of fresh media containing methylcellulose.
A slight excess was added to make up for evaporated media. The spheroids
were then transferred into GravityTRAP™ plates (InSphero) as follows. Each
well of the GravityTRAP™ plate was pre wetted with 70 μL of 4%
paraformaldehyde (PFA) (Electron Microscopy Sciences). The bottom piece of
the 96-well hanging drop GravityPLUS™ plate was removed and replaced with a
GravityTRAP™ plate. Once attached, 70 μL of PBS (Gibco) was added to each
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well of the GravityPLUS™ plate using the multipipettor causing spheroid
cultures to fall into the GravityTRAP™ plate below. After allowing 2 hours for
fixation, spheroids were embedded in the microarray or stored long-term at
room temperature.
3.3. 3D Microarray Formation
The microarray mold (Figure 4b & Figure 5) was filled with deionized
water. Microbubbles were removed using a 1 mL pipette and the microjetting
technique as described in Figure 5a. Removal of all microbubbles in microwells is
imperative for successful microarray formation. Breast cancer cell spheroids
were then placed individually into the microwells using a 1 mL pipette and the
gravitational transfer technique described in Figure 5b. Arrays of 24- (4x6) and
96-spheroids (8x12) were created using the 96-well mold. Arrays of 24-spheroids
were created using the central wells of the mold. Spheroid placement was
verified using inverted light microscopy (Carl Zeiss Axio Vert.A1). For each 24spheroid microarray created, 10 random spheroids were imaged and their
diameters were measured using the Zen 2 Imaging Suite (Zeiss) prior to agarose
infiltration for the study of processing effects.
Verified arrays were ready for agarose infiltration. This commenced with
the removal of water from the top, rectangular portion of the mold, leaving water
only in the micropillars (Figure 5c). UltraPure™ agarose (Invitrogen) was added
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to DI H2O at 3% (w/v) and boiled in the microwave until completely dissolved.
The molten agarose was then allowed to cool to 80ºC on the lab bench. The mold
was infiltrated with agarose by pipette into the corner of the mold at a rate of
approximately 0.1 mL/sec (Figure 5d). Larger flow rates may disturb spheroids in
microwells, causing them to become displaced. Enough agarose should be
added to form a slight meniscus above the height of the open mold. A tissue
cassette (Symport) was then mounted as shown in Figure 6 and additional
agarose was added to the top. The infiltrated mold was placed in the oven at
65ºC for 5 minutes to allow complete diffusion of water and agarose. The
microarray assembly was then removed and cooled at room temperature for 3060 minutes. The agarose transitions from a clear liquid to a slightly translucent,
cloudy white, firm gel when solidification is finished. The cassette may now be
removed carefully from the PDMS mold, bringing with it the spheroids
embedded in the micropillars of the array. Removal must be done slowly,
carefully and in a straight and even manner away from the mold so as to limit
pillar fracture.
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Figure 5. Microarray fabrication (with spheroids). Once the mold is completely filled
with deionized water, the pipette push button is fully depressed, and then the tip of
the pipette is submerged into the water in the mold. Once submerged, the push
button is released, bringing up water into the pipette tip. The pushbutton is then
depressed and released repeatedly while the tip is aimed at submerged
microbubbles. The resulting microjets will cause the successful ejection of all
microbubbles. (b) After successful removal of all microbubbles, spheroids are ready
to be transferred into individual wells. Note, the pipette tip should be trimmed
down approximately 1mm to increase its working diameter for spheroid transfer.
Spheroids are pipetted from GravityTRAP plates into a 1 mL pipette tip at a working
volume of 0.1 mL. The spheroid is visually located in the pipette tip, which is held
horizontally. Once visualized, the pipette tip is touched to the bottom of a single
well of the mold and turned vertically, allowing the spheroid to sink, due to gravity,
through the volume of water in the pipette tip. The spheroid finally comes to rest in
the bottom of the well after 10-20 seconds, depending on the spheroid diameter and
density. After successful placement of all spheroids, the microarray is then
centrifuged at 500 rpm for 5 minutes to remove any microbubbles created during
spheroid placement. Additionally, this centrifugation step makes sure all spheroids
are in contact with the bottom of the wells and in the same plane. (c) Water is
removed from the top, rectangular portion of the mold by placing the pipette tip in
the corner, and slowly pipetting water at a rate of approximately 0.1 mL/sec. Water
is now present only in cylindrical microwells. (d) Agarose is slowly and carefully
pipetted into the corner of the PDMS mold so as to not disturb the spheroids in the
microwells. The agarose and water slowly diffuse together. This is enhanced by
placing the assembly in the oven at 65ºC for 5 minutes, after addition of the tissue
cassette. This is a critical step because it is very hard to work with the spheroids in
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agarose directly. Beginning with water and later adding the agarose allowed
assembly of the arrays in an aqueous environment.

Figure 6. Cassette and completed microarray. (a) Cassette (orange) placement over
microarray which occurs after agarose addition. Once placed, more agarose was
added on top of the cassette to surround it with a continuous layer, securing the
array for removal from the mold. (b) After the agarose has been allowed to cool, it is
carefully removed from the mold, showing the finally assembly of the spheroids
embedded in the microarray. Care must be taken to ensure no pillars become
fractured as apparent in the top row of the image.

3.4. Paraffin Infiltration
The spheroid array, stabilized in agarose and physically fixed to a tissue
cassette, was placed in a graded series of 100 mL ethanol, HistoClear (National
Diagnostics) and paraffin (Fisher Histoplast LP) washes for 3 hours each on the
shaker at 65ºC as follows in Table 1:

77

Table 1
Paraffin infiltration procedure
Solution

# of washes X duration

1

50% ethanol

1 X 3 hours

2

70% ethanol

1 X 3 hours

3

85% ethanol

1 X 3 hours

4

95% ethanol

1 X 3 hours

5

100% ethanol

3 X 3 hours

6

HistoClear (National Diagnostics)

3 X 3 hours

7

Paraffin (Fisher Histoplast LP)

5 X 3 hours

After processing, the array was placed in a cassette receiver filled with
molten paraffin and allowed to cool to room temperature for solidification.
3.5. Histology of Spheroid Microarrays
Successful alignment of the mounted cassette with respect to the
microtome blade is absolutely crucial so that all spheroids may appear on the
same section. The alignment procedure used was as follows. First, it was
assumed that previous steps used to create the microarray resulted in an array of
spheroids that were parallel to the front surface of the tissue cassette. Now, the
tissue cassette had to be aligned normally to the axis of forward translation in
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both the vertical and horizontal directions. Vertical alignment was done using
the bubble level attached to the cassette receiver. This was completed first before
horizontal alignment. For the horizontal alignment, a blank cassette was placed
into the cassette receiver and the microtome blade was installed. The receiver
was then adjusted using an iterative process which involved setting the angle,
and using the wheel which allows for forward translation (without the slicing
motion), to match the blade up to the blank cassette. The blade position was
verified against the blank cassette at the cassette’s superior and inferior edges as
well as in between. Successful positioning was achieved when the blank cassette
came into contact with the blade at exactly the same time during forward
translation of the receiver. Visual verification of this contact was limited in
exactness to approximately 50 um, which proved adequate for the study. After
successful alignment of the blank cassette, the receiver was translated away from
the blade, and the cassette containing the microarray was mounted. For the sake
of the study, it was assumed that all cassettes were manufactured identically.
Slices were taken using a manual microtome (KEDEE KD-2258) at 20 um
beginning at the tip of the microarray pillars and through the distance of the
spheroids. The number of sections taken per block varied depending on
spheroid diameter; however, generally a number of sections spanning a distance
of [spheroid diameter]*150% were taken to insure that no spheroid samples were
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left unsliced. Sections were mounted onto adhesive microscope slides (Tru
Scientific - TruBond 380) starting at the first appearance of agarose wells and
concluded at the predetermined distance or once no more spheroids could be
observed visually. The paraffin sections were then placed in the oven at 60ºC
overnight to increase adherence to slides before the staining procedure.
Slides were deparaffinized, hydrated and stained with Hematoxylin and
Eosin (H&E) as follows:
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Table 2
Slide deparaffinization and H&E staining procedure

1

Solution

# of washes X duration

HistoClear

n X 15 minutes (until compete
removal by visual inspection)

2

100% ethanol

2 X 5 minutes

3

95% ethanol

2 X 5 minutes

4

DI H2O

2 X 5 minutes

5

Hematoxylin

1 X 10 seconds

6

DI H2O

1 X 4 minutes

7

Bluing agent (VWR Bluing Agent RTU)

1 X 1 minute

8

DI H2O

2 X 1 minutes

9

95% ethanol

1 X 30 seconds

10

Eosin

1 X 10 seconds

11

100% ethanol

1 X 1 minute

12

DI H2O

1 X 1 minute

13

Coverslip with aqueous slide mount

indefinite

Fluoro-Gel with TES Buffer (Electron Microscopy Sciences) was used as
the aqueous coverslipping agent.
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Figure 7. Process overview.

3.6. Results and Discussion
3.6.1. Optimization of methodologies. Each step of the process
underwent iterative design beginning with mold creation. The first iteration of
the positive mold (Figure 4a) was machined using an end mill with 1º of relief. It
was soon realized that regardless of agarose concentration, it was difficult to
remove the agarose/spheroid/cassette assembly from the mold without
fracturing pillars. The part was re-machined with 5º of relief, greatly improving
micropillar pullout to 90-95%.
Even though the literature contains some resources on breast cancer
spheroid formation with cell line HTB-126, there were numerous engineering
challenges associated with achieving successful culture and fixation in our
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laboratory. The first major problem was drop evaporation during 3D culture.
This occurred predominantly in the drops along the outer rim of the culture plate
even though it did effect all drops to a degree. To combat this problem, 2%
agarose solution was placed in the top rim of the middle dish of the
GravityPLUSTM system. Ultimately, this was not a great solution. When
InSphero changed the design of the GravityPLUSTM in the summer of 2015, this
approach was no longer feasible. Another attempt included hydrating the pad
with sterile deionized water instead of PBS to increase the partial pressure of
water in the chamber as the ions in the PBS act to trap the water to its liquid
state. Water reduced drop evaporation but further improvement was necessary.
Simply adding more culture medium to deficient drops was not adequate as this
created a hypertonic cellular environment. The final solution was to use
deionized water in the bottom hydration chamber and to wrap the culture dish
in parafilm. This combination prevented drop evaporation and actually
increased the size of the drops at times. Regardless, this was a key step in the
successful culturing of spheroids.
Once drop volume was stabilized, the next difficulty was getting cells to
consistently form dense spheroids instead of loose aggregates. We hypothesized
aggregates did not fully come together because (a) over confluence during 2D
culture created significant numbers of necrotic cells or (b) improper culture
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conditions did not promote aggregation. Now, some changes were made. Cells
were consistently washed with PBS during each media change to remove dead or
loosely adherent cells, and hanging-drop culture was performed with the
addition of 0.24% methylcellulose. Additionally, cells were only cultured to
approximately 90% confluence to avoid necrosis. These changes allowed for
consistent spheroid production of over 80% (>75/96 spheroids), and on occasion
>95%, per culture plate.
As previously mentioned, agarose concentrations were varied to
determine the optimal concentration for maximizing the pullout of micropillars.
As agarose concentration was increased, pillars formed more rigidly and were
fractured less often. The competing mechanism was that increasing agarose
concentration increased the viscosity of the gel. High viscosity agarose was
difficult to work with especially as it cooled rapidly. The optimal concentration
was experimentally determined using molds with no spheroids. It was found
that at concentrations of 0.25, 0.50 and 0.75% the resulting gel was unable to
properly harden for pullout. At concentrations of 1.0 and 1.5%, the gel was able
to harden in many wells, but did not pull out consistently. Additionally, the
water in wells around the outer rim of the mold did not mix sufficiently with
incoming agarose, leading to increased fracture of edge micropillars during
pullout. This was due to water accumulating around the outer rim of the mold
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as a result of surface tension. As agarose was added to the mold with spheroids,
its effective concentration around the rim was reduced due to the presence of
water. All concentrations above 1.5% tested (2.0, 3.0, 4.0%) consistently pulled
out over 90% of pillars, with some successfully pulling out 100%. As a result we
elected to begin using 2% agarose with molds housing spheroids.
The results of embedding spheroid microarrays with 2% agarose were hitor-miss. Occasionally, pullout of >90% pillars was achieved. Often, as many as
50% of pillars failed to be removed. We hypothesized that a boundary layer of
water was being created around the spheroid contributing to pillar fracture
(Figure 8).

Figure 8. Hypothesized pillar fracturing mechanism.
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Evidence for this was seen in spheroids left behind in the mold as a result
of fractured pillars. The agarose around these spheroids seemed unusually
hydrated. Additionally, histology confirmed that agarose was not completely
surrounding the spheroids. We also noted that this finding may have been due
to spheroid shrinkage during the dehydration process. A gap could often be
seen between the boundary layer of the spheroid and the agarose in successfully
removed micropillars (Figure 9). To combat this, agarose concentration was
increased to 3%. Additionally, after the addition of agarose and placement of the
cassette, the assembly was incubated for 5 minutes in the oven at 65ºC to
promote diffusion and slow cooling of the gel. These two changes allowed for
consistent pullout of greater than 90% of micropillars. After successfully solving
the problems of culture and microarray fabrication, processing and sectioning of
the array was generally straightforward.
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Figure 9. Image of sectioned spheroid showing a gap between the boundary layer of
a spheroid and that of the agarose well.

3.6.2. Quantifying the effectiveness of the 24-spheroid block system.
The effectiveness of the system was first studied on array's of 24 spheroids (4x6).
After sectioning each array, the best five slides were chosen for analysis. "Best"
was experimentally determined to be as follows. First, ten random spheroids
were imaged and measured before processing. Each spheroid was approximated
as an ellipse with measurements taken for both the long and short axis of the
spheroid. These were used to determine the "pre-processing average maximum
area" of the spheroids for a given block. Maximum in this case refers to the
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section of a given spheroid having the largest cross-sectional area, as there could
be 10 or more sections of an individual spheroid. After sectioning, each spheroid
on each section was measured. Only spheroids with areas >25% of the preprocessing maximum average were considered successfully processed. The five
sections with the greatest number of spheroids processed were considered the
"best" and chosen for analysis. Table 3 shows the results by block.

Table 3
24-block study overview
Block

Pre-processing average

% recovered per section

Post-processing

maximum area (stdev)

(out of 24)

maximum area (stdev)

B12

1.855E5 µm2 (2.213E4)

80.8% (19.4)

1.319E5 µm2 (5.434E4)

B13

1.698E5 (2.014E4)

90.0% (21.6)

1.152E5 (3.869E4)

B15

1.299E5 (1.764E4)

79.2% (19.0)

9.416E4 (2.298E4)

B17

1.959E5 (1.418E4)

86.7% (20.8)

7.900E4 (2.025E4)

Statistical analysis was performed between the pre-processing average
maximum area (n=40) and the post-processing average maximum area (n=37).
The null hypothesis was that processing has no effect on the spheroid maximum
area. The standard deviation of the post-processing group was determined to be
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7.021E3. Since the sample means were 1.728E5 (pre) and 1.312E5 (post), the Zscore was calculated to be 5.924 standard deviations away from the preprocessing mean. This correlates to p=1.594E-9 ≈ 0. Therefore, the null
hypothesis must be rejected and we conclude that processing has a direct effect
on spheroid area.
Leading hypotheses on the mechanisms effecting the system include
spheroid shrinkage during dehydration through ethanol, and compression
during sectioning. Shrinkage during dehydration is straightforward. As water is
forced from cells in the spheroid and replaced with a less dense liquid, the
structure naturally tends to contract, even after fixation. This mechanism may
also account for the separation between the boundary layers of the spheroid and
agarose as seen in Figure 9, as the spheroid and agarose may initially share a
boundary layer until the spheroid is shrunk by dehydration and ripped away
from the agarose. This theory would tend to discount the pillar fracturing
mechanism hypothesis.
Compression during sectioning is less intuitive to a non-histologist. As a
wax section is sliced very thin, on occasion the ribbon retrieved is shorter in
distance than the width of the block (distance of the edge normal to the edge of
the blade is under consideration). This results in shrinkage along the y-axis of
the block as much as 5 or 10%. A finite element analysis results in each element
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being compressed this percentage along the y-axis, including the bits of tissue
embedded within.

Figure 10. Spheroid sectioning geometry.
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Figure 10 is a diagram which represents n consecutive sections of a
spheroid with radius, R at a section thickness, t. The equation along the edge of
the circle between (0,0) and (R,R) is
,

(Eq. 1)

where
.

(Eq. 2)

which simplifies to
.
The area of the resulting spheroid with radius
.

(Eq. 3)
is

(Eq. 4)

Equations 3 and 4 were used to calculate the radii and areas of optimal
spheroids with a known radius, R, on consecutive sections. Note that combining
Equations 3 and 4 and eliminating constants results in the relationship,
,

(Eq. 5)

which will be important in figures displaying results of sectioning (Figures 3.1114).
Figure 11 shows imaging of a single spheroid before processing (A) and on
seven consecutive sections after histology (B-H) at 10x (scale bar, 100 µm). Figure
12 shows 11 consecutive sections of a spheroid after histology in color at 20x.
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The scale bar is 50 µm. Figure 13 shows eight sections from block 15 as viewed
by the naked eye.

Figure 11. Spheroid pre- (A) and post-processing (B-H).
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Figure 12. Eleven consecutive sections of a single spheroid after H&E staining at
20x.
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Figure 13. Eight sections from block 15 as viewed by the naked eye.

The same ten random spheroids were imaged and measured on each
section as done for pre-processing measurements. Measurements taken were
used to calculate the spheroid's area approximated as an ellipse. These areas
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were plotted against the section numbers. For block 15, the spheroids with
largest area were centered to section number 9 in Figure 14. The other spheroids
were normalized around section number 9 keeping intact the relative number of
sections apart. The post-processing maximum areas were used for calculating
column 4 of Table 1. The area of an optimal, spherical spheroid with diameter
350 µm was plotted for reference.

Figure 14. Three of the best spheroids from Block 15.

Figure 14 shows that spheroid area correlates well to the shape of the
optimal spheroid curve for three different spheroids from block 15. Spheroid
area increases as the center of the spheroid is approached during sectioning.
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Each section was taken at 20 µm; therefore, the total amount sectioned is
equivalent to the product of section number and 20 µm. The eleven sections
taken from number 2 to number 12 in Figure 13 span a distance of 220 µm. The
rationale for centering the maximum area secretions to section number 9 was to
account for tilt and inconsistencies in spheroid diameter, allowing for better
visualization of the trend across different spheroids in the group. In order to
achieve all maximum spheroid diameters on a single section, the user is required
to section the block with perfect 0º tilt5 on both x- and y-axes. Additionally,
initial spheroid diameters would have to be uniform with perfectly round
geometries. Further complications include spheroids all evenly touching the
bottom of the mold during agarose embedding; often some become dislodged by
the incoming agarose and rest a short distance away from the tip of the
micropillar. Due to these factors, it is unreasonable at this time to anticipate
maximum area sections occurring on the same histological section as the
variance in spheroid diameter is relatively high due to the nature of culturing
biological samples. To combat this, the maximum area of each spheroid was
determined by section number, and the rest of the data was normalized (shifted)
to the this section. Figure 15 shows 8 different spheroids processed from Block 15

5

Tilt is further discussed in section 3.6.3 Tilt analysis.
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which appeared on at least 7 of 8 sections. The dashed line represents the
polynomial order 2 fit of the optimal 350 µm spheroid scatter plot.

Figure 15. All spheroids from Block 15. Only spheroids appearing in at least 7/8
blocks shown.

Figure 16 is identical to Figure 15 but contains additional polynomial
curve fits of order two. R2 values are displayed for reference. Of the eight
spheroids tested from Block 15, only one showed a low correlation fit (C03,
R2=0.5281).
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Figure 16. Spheroids from Block 15 with curve fitting data.

Curves were fit with a polynomial function of order 2 to match the
geometrical relationship derived in Equation 3.1. This was done similarly in
Figure 17 for block 17.
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Figure 17. Spheroids from Block 17 with curve fitting data.

Table 4 shows a heat map of the best five sections from each of the four
blocks summed together for a total of 20 sections. It would appear there is no
direct trend for the successful processing of spheroids; although columns A-C
were significantly more successful than D-F. This is likely an artifact of random
error accumulating from the following factors: sectioning beginning past the
center of the spheroid, ellipsoidal spheroid geometry with odd orientation, or
systematic error arising as a result of the mold, microtome or operator.
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Table 4
Heat map for all sections of 24-spheroid blocks

A
18
18
19
18

1
2
3
4

B
17
17
19
20

C
16
18
19
20

D
14
17
13
15

E
16
15
13
16

F
14
15
17
18

3.6.3. 96-spheroid blocks. Blocks of 96 spheroids were not analyzed as in
depth as those of 24 spheroids. However, the resulting histological sections were
analyzed to determine the average recovery rate of spheroids between three
different blocks. Table 5 contains data for 96-spheroid blocks. Slides counted had
>25% of spheroids successfully processed (24/96). The blocks are listed in
chronological order. Note improvements between early and later blocks
showing evolution of the process. Figure 18 shows four of the best sections from
block A3.
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Table 5
96-spheroid block data
Block

A17

# of Sections

Sections with

Sections with

Sections with

5-best

(distance)

>50%

>75%

>90% recovery

average

recovery

recovery

4/7

0/7

7 (140 µm)

(percentage)
0/7

56.6/96
(59.0%)

A2

9 (180 µm)

0/9

0/9

0/9

36.4/96
(37.9%)

A3

14 (280 µm)

13/14

7/14

0/14

82.8/96
(86.3%)

A4

13 (260 µm)

9/13

0/13

0/13

60.4/96
(62.9%)
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Figure 18. The four best sections from a 96-spheroid block, A3.

3.6.4 Tilt analysis. Analysis of tilt began with deriving an equation for the
length of chord AB in Figure 19.
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Figure 19. Geometrical setup for the derivation of the tilt equation.

From the law of cosines we have the relationship,
,

(Eq. 6)

and from the power of a point theorem we have,
,

(Eq. 7)

remembering that
and

,

(Eqs. 8 & 9)

the resulting length of chord AB is
.
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(Eq. 10).

The relationship was expanded to solve for three cases: tilt in a 24-, 48and 96-block. This was done using SolidWorksTM to setup the geometry and
measure the relevant chords while driving the dimension of the angle. The data
tables are available in Appendix A. The intersection of the zero tilt line and the
cutting edge line was considered the "focal point of tilt." As the angle of tilt, Ɵt
(the angle between the zero tilt line and the cutting edge line) is increased, the
resulting maximum spheroid diameter recovered is reduced. This new
maximum diameter is pictured as chord AB in the Figure 19. In larger arrays,
spheroids further from the "focal point of tilt" diameter's rapidly become shorter.
The scenario was simplified to account for only the long axis, the axis requiring
more precision to successfully cut all spheroids in plane. It was assumed that the
tilt along the short axis would be similar, and thus have a less profound effect
overall. Figure 20 shows the long axis, focal point of tilt, and resulting diameters
for a row of spheroids sectioned at three different angles (green=0, yellow=low
tilt, red=high tilt). The lines below the spheroids represent the diameter of a
spheroid sectioned using the given angle of cut (represented by color). Notice
how spheroids furthest from the focal point of tilt are most affected.
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Figure 20. Cuts of tilt=0º, 0.5º and 1.0º (green, yellow, red) and the resulting
maximum spheroid diameters (below as the length of colored lines). Lengths are for
a 24-block (A), a 48- block (B), and a 96-block (C) with ideal spheroids.

The ratio of the shortened diameter (yellow and red) to the maximum
diameter (green) was called the area reduction fraction. This decimal was
subtracted from 1 to get the percentage area lost and plotted in Figure 21 versus
the angle of tilt, Ɵt. The percent area lost was calculated for Ɵt values between 0º
and 2.25º.
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Percentage Area Lost vs. Degrees of Cut Tilt
for ideal spheroid 500 um
1.200
1.000

Error

0.800
24 block

0.600

48 block

0.400

96 block
0.200
0.000
0.000

0.500

1.000

1.500

2.000

2.500

Degrees of Tilt (º)

Figure 21. Percentage of area lost as a result of increasing tilt values.

Unsurprisingly, the spheroid furthest from the focal point in 96-spheroid
blocks increased in error the fastest; error in 24-spheroid blocks increased the
slowest. For 500 µm diameter spheroids in 96-blocks, Ɵt values greater than 1.0º
completely missed the outermost spheroid. This angle is equivalent to missing
the mark by 255 µm on each end of the block. Angle for 100% error in the most
distant spheroid first occurred at 1.6º for 48-spheroid blocks and 2.25º for 24spheroid blocks. These angles do not correlate with acceptable results. In order
to keep sectioning error below 10%, angles of 0.70, 0.55 and 0.30º must be
achieved for blocks of 24-, 48- and 96-spheroids, respectively.
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Next, tilt was quantified experimentally. During sectioning, it was
observed that pillars did not always show up uniformly. Often, one side of the
block would show micropillar wells before another side. Within a few sections,
all pillars would usually become present. Assuming all pillars remained flat
through processing, the tilt could be calculated based on vertical displacement
(quantified by number of sections) and horizontal displacement (number of new
pillars present). This pattern can be observed in Figure 22 which shows the
pattern of appearance of new micropillars across sections A-E for a given angle
of tilt.

Figure 22. Method of quantification and calculation of experimental tilt.

Table 6 shows the experimentally determined tilt values for 4 different
blocks. Not all blocks showed such an obvious pattern, and others contained
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pillars which clearly did not stay flat through processing. Incomplete
dehydration of the agarose microarray during initial ethanol washing steps often
leads to swelling and the formation of a concave meniscus along the tips of the
micropillars.

Table 6
Experimentally determined tilt
Block

X-tilt

Y-tilt

B17

0.112º

0.315º

A1

0.116

0.0749

B5

0.0499

0.103

B7

0.180

0.124

Mean

0.115º

0.154º

Std. Dev.

0.0530º

0.109º

Average X-tilt (the long length of the block as described in the tilt section)
was 0.115º correlating to about 0.2% error for a 24-spheroid block, a very low
finding. The Y-tilt was slightly greater at 0.154º. This error was not theoretically
determined but is less than its equivalent 24-block X-error of 0.5%. The reason
for increased error is the alignment mechanism. The methodology of alignment
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correlating to X-tilt error involved placing a blank cassette in the microtome and
comparing its orientation visually against the blade across its whole length. This
method allowed for very accurate alignment. There was no way to replicate this
alignment strategy for Y-tilt. Y-tilt was done strictly using the bubble level
attached to the microtome and visual inspection. This explains the larger
average error and standard deviation. Overall, tilt values were very low and
could not alone account for reductions in the percentage of spheroids recovered.
3.6.5. Average time and costs saved to a user versus conventional
methods. Conventional methods for histology of MCTS involve embedding one
or a few spheroids in a wax block using no microarray. The greatly increases the
number of blocks to be cut to perform the identical study using a microarray.
Additionally, it requires the histologist to search for spheroids during cutting
and staining. We propose a value proposition of using our microarray technique
based on time and materials saved for an experiment involving 108 samples per
patient. The sample number is based on an experiment which explants a
patient's primary cancer cells, creates spheroids and subjects them to 12
treatment combinations, 3 treatment durations with a minimum of 3 replicates
per group for statistical significance.
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Table 7
Comparison of conventional and microarray methods
Item

Conventional Methods

96-spheroid microarray

Processing and embedding

$3/specimen

$100/microarray

Unstained slides from

$3 for first slide, $1/slide

$3 for first slide, $1/slide

paraffin block

additional (10 slides)

additional (10 slides)

IHC stain from slide

$18/slide x 10 slides

$18/slide x10 slides

Digital slide scanning 20x

$6/slide x 10 slides

$6 x 10 slides

Total

$255/spheroid

$3.67/spheroid

The conventional group would need to fabricate, section and stain 108
individual blocks, while the 96-spheroid microarray group would only need to
fabricate 2 blocks (assuming 85% recovery, resulting in excess data). It is
unsurprising to see that processing 96 spheroids at a time versus one spheroid is
98.6% cheaper per spheroid. All pricing is directly from the CHOP Pathology
Core except for microarray processing and embedding. This was assumed to be
$100 (~$50/hour for two hours of labor). The additional cost in preparing a 96spheroid block is more than made up for in terms of cost of raw materials and
time. Even if as many as five spheroids were processed in parallel bringing the
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conventional methods' cost to $51 each, the value proposition would still be
92.8%
3.6.6. Failure mode analysis. There were numerous failure modes at each
point in the process which could ultimately result in the lack of spheroid
recovery. After spheroid placement, a common occurrence was disturbance of a
spheroid in one well due to the placement of a spheroid in an adjacent well. This
problem could often be corrected, but on occasion the error was uncorrectable.
This resulted in a well with no spheroid due to dislodging. This spheroid may
have come to rest in no well, or more often, in another well causing a double
spheroid well. This failure mode was also common during agarose infiltration.
During agarose infiltration, other modes of spheroid dislodging included
disturbances during water removal and disturbances while placing the cassette
and adding agarose on top. As previously discussed, removal of the microarray
from the mold almost always resulted in the loss of >5% of micropillars.
Processing had the potential for great effects on the agarose/spheroid
microarray. Serious care was taking to mitigate these all too common failure
modes. The first failure mode during processing was too rapid dehydration.
This failure was caused by subjecting the array to too high initial ethanol
concentrations during the dehydration steps. The result of this failure was
curling of the agarose array resulting in a concave shape across the micropillars.
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Ultimately, this lead to the inability of the array to be sectioned in-plane. A
similar failure involved incomplete dehydration. This allowed water to remain
in the microarray through future processing steps, also causing warping and
difficulty during sectioning.
Similar problems were encountered during the transition between
HistoClear and paraffin wax. Many blocks were processed through paraffin wax
that were contaminated with HistoClear from previous blocks. The result was
solid blocks containing significant HistoClear. Sections of these blocks curled up
or fractured, and thus were not able to be mounted to slides.
A few additional failure modes presented during sectioning of the
microarray itself. The first of these, tilt, was previously discussed in depth.
Other errors included the fracture of sections perpendicular to the blade as a
result of a chip, dent, or a bit of wax stuck on the blade from cutting a previous
section.

Although possible, it was difficult piece these types of sections back

together on a single microscope slide. Generally, these sections were lost.
Another failure mode occurred during transfer of the section into the
water bath for mounting to a slide. On occasion a section would stick to a tool,
the user's glove, or become folded during placement into the bath. These all
resulted in the loss of a whole section.
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After baking slides, they were ready for staining. Very few losses
occurred during staining; although, with very low frequency, some spheroid
sections fell off into the staining solutions. Coverslipping occurred with no
losses. Table 8 summarized the compounding errors encountered during the
experiment.
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Table 8
Errors incurred throughout microarray fabrication and processing optimization
Error

Cause

Result

spheroid displacement

disturbance due to adjacent

wells with two or zero

spheroid placement, water

spheroids

removal, or agarose additon
fractured micropillar

incomplete agarose diffusion, no micropillar and
lack of removal from mold

therefore no spheroid in a
single well

too rapid/incomplete

poor dehydration sequence

dehydration

swelling and warping of
microarray

HistoClear diluting paraffin

failure to properly change

wax

HistoClear solution

tilt

improper microtome

inability to section block

out of plane sectioning

blade/block alignment
fracture of wax section

chip, dent or wax bit on

wax section split

during cutting

blade

horizontally in two

wax section folding or

section stuck to tool, glove or

irreversible loss of section

becoming deformed

folded during placement in
bath
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Chapter 4
Validation of Tissue Microarray - Iron Oxide Nanoparticle Penetration Study
4.1. Experimental Procedure
The following procedure was used to determine the penetration and
potential chemotherapeutic potential of 5k Da-polyethylene glycol coated
superparamagnetic iron-oxide nanoparticles (5k-PEG SPIONs) on HTB-126
breast cancer cell spheroids. Both 2D and 3D culture systems were tested for
comparison.
4.1.1. 2D culture and histology. Cells were collected from one confluent
T75 flask and resuspended in 40 mL of fresh culture medium. In one 24-well,
flat-bottom, adherent culture plate, 1 mL of cell suspension was added to each of
16 wells. Similarly, 1 mL of cell suspension was added to all 24-wells of a
separate 24-well culture plate. In total, 40 separate monolayers of HTB-126
breast cancer cells were cultured. Plates were incubated until cells reached
confluence. Media was changed every other day. Four wells were fixed with 4%
paraformaldehyde and without incubation with SPIONs (negative control).
Fixation was performed for two hours. Cells were washed with PBS and left to
sit at room temperature in fresh PBS awaiting staining.
The remaining 36-wells contained 12 experimental groups of n=3
consisting of three dosages (1 µg/mL, 10 µg/mL, 100 µg/mL) and four time points
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(1d, 2d, 3d, 7d). After incubation for the prescribed duration, cell monolayers
were fixed for two hours in 4% PFA, washed with PBS, and hydrated with PBS
until staining.
2D cultures were not embedded and sectioned, but instead stained
directly in culture plates following fixation. Preparation of the stain involved
creating 20% aqueous solution of hydrochloric acid (20 mL concentrated
hydrochloric acid added to 80 mL distilled water) and 10% aqueous solution of
potassium ferrocyanide, trihydrate (K4Fe(CN)6·3H2O (10 g potassium
ferrocyanide Sigma Cat# P-3289, dissolved in 100 mL distilled water). The two
solutions were mixed immediately before staining. 1mL of the solution was
added to each well of the fixed 2D cultures and allowed to incubate for 30
minutes. The wells were then washed three times with distilled water and
counterstained with 1 mL nuclear fast red stain for five minutes. After two more
washes with distilled water, plates were imaged and photographed using the
Zeiss AX10 microscope and Zen Imaging Suite.
4.1.2. 3D spheroid formation and incubation. Breast cancer spheroids
with an initial density of 30,000 cells per 40 µL droplet were formed as described
in 3.2 Culture of HTB-126 Breast Cancer Spheroids. Spheroids were transferred
with PBS to a sterile GravityTRAPTM plate without fixation using the same
transfer technique that was used for placing spheroids into microwells (Figure
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5b). Due to normal losses during culture, two full plates of spheroids were
necessary to fill one 96-well GravityTRAPTM plate with a single spheroid in each
well.
The spheroids were then incubated with culture medium (DMEM
supplemented with 10x FBS and 1x penicillin/streptomycin) containing 5k-PEG
SPIONs received from Auburn University via Dr. Alan David's lab as described
in [89]. Twelve experimental groups were created using two SPION dosages (1
µg/mL, 10 µg/mL) and six incubation lengths (1 hr., 4 hrs., 12 hrs., 24 hrs., 3 days,
7 days) for n=8 of each. Unfortunately, not enough particles were provided for a
third dosage group of 100 µg/mL. Negative control spheroids were fixed
without incubation (n=8). Calf's liver was dehydrated, infiltrated and embedded
with paraffin for use as a positive control in the Pearl's Prussian Blue staining
protocol. Upon completion of SPION incubation, each spheroid was transferred
to a new GravityTRAPTM plate containing 4% paraformaldehyde (PFA) for
fixation. Fixation proceeded for 2 hours followed by removal of PFA, one PBS
wash, and the addition of PBS for long-term storage at room temperature until
remaining spheroids were ready for embedding into a microarray.
4.1.3. Microarray fabrication and histology. Spheroid groups of n=8
began the incubation process. However, some spheroids disassembled and
others were lost leaving groups of n=5 to n=8. The remaining spheroids were
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assembled into two separate microarrays using the center 48-wells (6x8) of each.
Control spheroids were placed in the first four wells of the top row (wells A1A4). After processing, spheroids were sectioned at 20 µm. The best six slides
were chosen for analysis6. Slides #1, 3 and 5 were sent to the Children's Hospital
of Philadelphia Pathology Core for Prussian blue staining (nuclear fast red
counterstain) and digital slide scanning at 20x. Slides #2, 4, and 6 were stained
using an identical Prussian blue stain/nuclear fast fed counterstain protocol in
our own lab. The staining protocol from [90] begins with deparaffinization and
hydration of sections to water. The protocol proceeds with creating and
combining the same two reagents (20% hydrochloric acid, 10% potassium
ferrocyanide) as discussed in 4.1.1 2D Culture and Histology. Hydrated sections
resulting from sectioning of the 3D spheroid microarray were incubated in the
mixed solution for 30 minutes. Slides were then washed three times with
distilled water and counterstained with nuclear fast red for five minutes. After
two more washes in distilled water, sections were coverslipped with aqueous
mounting medium and imaged using the AX10 microscope and software.

Slides were chosen so that a minimum of n=3 for each spheroid experimental group as not all
spheroids were on each slide.
6
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4.2. Data Collection
2D and 3D culture images were analyzed using ImageJ. Specifically,
images were loaded into ImageJ, converted to 32-bit/grayscale, and threshold
analysis was used to determine the percent area stained.
2D culture images were analyzed using the following thresholding values
to specifically highlight the Prussian blue stain: hue 85-128, saturation 44-134,
brightness 0-255. The software was used to measure the percentage of area
stained.
Before analysis, 3D spheroid images were separated into four specific
cores using Paint.net, an image editing program, as shown in Figure 23. Core 1
was the central region of the spheroid ranging from the center to a distance of
0.25r. The other cores 2, 3, and 4 were rings covering consecutive area ranges
between 0.25r and 0.50r, 0.50r and 0.75r, and 0.75r and 1.00r, respectively.
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Figure 23. Core 4 through 1 shown from left to right for n=3 spheroids of a single
group.

No analysis was performed for Prussian blue staining. Thresholding
analysis between values of 67.5 and 184.5 were used to determine the degree of
the nuclear fast red staining. Nuclear fast red stains nuclei red and the
cytoplasm pink. As evident from the pictures, no positive Prussian blue staining
was observed. The area enclosed and percentage stained was measured for each
core. These percentages, along with standard deviations in the experimental
groups, are reported in Table 9. Averages and standard deviations across single
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time points, individual cores, and for all samples were calculated. These values
were used to collect information on the density of cells by region in the spheroid.

Table 9
Percentage of staining by cores and time points for all dosages
Core 1

Core 2

Core 3

Core 4

Time
Averages

Day 0

77.7 (12.8)

80.1 (10.4)

84.3 (9.44)

79.9 (5.94)

80.5 (8.85)

Day 0.5

71.5 (2.58)

68.9 (2.96)

70.6 (3.71)

82.4 (7.35)

73.3 (6.77)

Day 1

98.9 (0.806)

98.6 (0.417)

97.9 (2.23)

93.3 (3.04)

97.2 (2.86)

Day 3

74.6 (36.9)

63.2 (30.6)

65.3 (32.2)

55.2 (40.2)

64.6 (30.8)

Day 7

72.1 (32.6)

76.4 (17.7)

64.6 (17.0)

44.3 (12.8)

64.3 (22.3)

Core

79.0 (22.0)

77.4 (18.7)

76.5 (19.5)

71.0 (25.0)

75.98 (21.1)

Averages
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4.3. Results and Discussion
The following images were taken of 2D monolayer cultures after Prussian
blue staining. The negative control is not pictured. Dosages increase from left to
right while incubation times increase from top to bottom.

Figure 24. Staining of 2D cultures. Rows from top to bottom are days 1-3, dosages
from left to right are 1, 10, 100 µg/mL.
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Thresholding values were used to calculate the percentages stained by
Prussian blue. Error bars bracket one standard deviation from each experimental
group (n=3).

Prussian Blue Staining Results
70

Percentage Positive Stain

60
50
40
1ug/mL
30

10ug/mL
100ug/mL

20
10
0
day 1
-10

day 2

day 3

day 7

Incubation length

Figure 25. Percentage staining by dosage and incubation time. Error bars denote
one standard deviation of the sample mean.

The results show that there was no significant difference between staining
for dosages of 1µg/mL and 10 µg/mL. Significant differences in staining were
observed between both 1 µg/mL and 100 µg/mL, and 10 µg/mL and 100 µg/mL
dosages. It would appear that between 10 µg/mL and 100 µg/mL there exists a
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specific concentration which promotes increased uptake of SPIONs into cell
monolayers. This is an interesting result moving forward as it helps explain
what may have been observed in 3D culture experimentation.
The following images (Figure 26 & 27) show a lack of positive Prussian
blue staining across all 3D spheroid cultures, regardless of dosage or incubation
time. Note that between removal of the microarray from the mold, sectioning
and slide mounting, the orientation is effectively mirrored over the y-axis as a
result of the process. This leaves the control spheroids (n=3 pictured in this
section) in the top right corner of the figure. Experimental groups begin on the
right and move left across a single row. It is unfortunate that not enough
particles were provided to study the dosage of 100 µg/mL on spheroid cultures.
It is recommended that this is the starting dosage for future experiments.
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Figure 26. Block T1 Prussian blue stain (nuclear fast red counterstain).
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Figure 27. Block T2 Prussian blue stain (nuclear fast red counterstain).

The lack of positive Prussian blue staining in 3D culture could be
indicative of multiple results. One obvious cause is experimental error arising
from improper staining technique. This is relatively unlikely due to successful
staining of 5k-PEG SPIONs in similar spheroids of a different cell line using an
identical procedure. However, we should note that these spheroids were slightly
larger, not as densely packed, and incubated for a period of 3 days. Figure 24
shows positive staining for ferric ion in a rhabdomyosarcoma sarcoma (CRL2061) spheroid at 20x indicating procedural success.
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Figure 28 . Prussian blue stain (nuclear fast red counterstain) of a CRL-2061
spheroid of approximate diameter of 1.2 mm.

Unfortunately, no breast cancer spheroids contained a similar pattern of
SPION penetration around the periphery of the tissue. The goal of this
experiment was to determine penetration of these particles into different regions
of the spheroid over time; however, this was not successful.
Another hypothesis for the lack of staining is particle removal through
diffusion during microarray processing. This would explain the presence of
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particles in 2D and the lack of particles in 3D, as only 3D cultures were subjected
to extended immersion in various reagents before staining.
Other hypotheses which explain the lack of positive ferric ion staining
include multicellular tumor resistance. Discussed in Chapter 2, this resistance is
the result of many cells becoming densely packed and working together to resist
foreign agents, including chemotherapeutic drugs. Additionally, it is possible
that breast cancer cell line HTB-126 does not have proteins with the ability to
internalize SPIONs, while cells in the rhabdomyosarcoma cell line CRL-2061 are
fully capable. Although, this is unlikely due to positive staining in 2D and the
fact that all human (and eukaryote cells for that matter) cells possess similar
integral membrane proteins. Previous research has shown successful penetration
into cell monolayers [89]. Further experimentation needs to be performed before
ruling out SPION penetration in 3D tissues. On occasion, nonspecific, positive
ferric ion staining was observed which may be attributed to contamination at
some point along the process, processing effects, or actual particle penetration.
One result noted was that spheroids seemed to go through three distinct
phases of assembly, growth and disassembly across all four cores. The assembly
phase can be described as the time between initiation of hanging drop culture
and Day 0 of nanoparticle incubation. Once spheroids were assembled, they
were incubated with particles. The next day saw a steady increase in spheroid
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counterstaining density indicating cellular growth and compaction. The next
two staining time points, day 3 and 7, saw progressive deterioration of area
stained in the spheroids attributed to disassembly of microtissues. This
deterioration was not observed in any control spheroids; therefore, this result
may likely be attributed to the chemotherapeutic effects of iron in the drug.
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Chapter 5
A Mechanical Solution for Automated Spheroid Transfer
5.1. Mechanical Transfer Ideation
The idea to automate the placement of spheroids into microwells was a
natural technological advancement in the design of the system. Additionally, it
was recommended by grant reviewers as a prospective way to increase the
innovation potential and utility of the technology. The current system of
spheroid transfer, although precise and with 100% success rate, is slow and very
tedious. An ideal system would transfer spheroids directly from hanging-drop
culture plates and into the microarray mold with low or zero losses. In this case,
spheroids would need to be fixed either while in hanging-drops, or in the mold
after transfer. Upon successful development of mechanical transfer technology,
such decisions could be properly tested and made. There is a need to efficiently
collect and transfer spheroids from culture into the microarray mold in an
automated or mechanical fashion in order to improve the speed of the process by
100%. The current system takes between 1.5 and 2.5 hours to place 96 individual
spheroids (~60-90 seconds each). Reducing this time would greatly reduce the
labor cost associated with microarray fabrication (Table 4).
Design of the system began with the consideration of three different
transfer mechanisms. The first design considered was a simple system to house a
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96-well plate and connect it to the microarray mold using a series of small plastic
tubes. It would operate on the principle of spheroid transfer through
gravitational fluid flow. The unknown aspect of this design was whether the
enough force could be generated to move a spheroid through a thin tube with
water and gravity alone. It was hypothesized that the surface tension of water
may act to inhibit water and spheroid movement through a vertical tube due to
the geometrical constraints of spheroid size, hanging-drop plate dimensions, and
microarray mold geometry. The second design considered was similar to the
first, but would incorporate a vacuum to assist in overcoming frictional forces or
those arising due to water tension.
Design number three involved building a system that would operate with
the assistance of a centrifuge. The governing design principle behind this device
was to use the centrifugal force to transfer spheroids; the design would be
required to mechanically connect hanging drop plates to the mold in a compact
format so as to fit in the centrifuge's plate holder attachment. The design would
then use the force of the centrifuge to overcome other forces present and one
place the spheroid into the bottom of each microwell. Ultimately, it was
determined to proceed with design one for simplicity and avoid over
engineering. Future iterations would consider the use of other sources of force
for spheroid transfer.
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5.2. Mechanical Design
In order to achieve the design goals discussed for design one in 5.1
Mechanical Transfer Ideation, it was decided that the first prototype would consist
of 4 fundamental parts: a rigid piece that fits existing pins of GravityTRAPTM 96well plates to collect spheroids directly from culture; a rigid piece that fits the
existing geometry of the microarray mold, containing a channel for each
spheroid to flow downward into the mold; a series of 96 narrow, polymer tubes
that connect the two parts; and a water vat on top to increase the pressure head
of the system.
5.2.1. Microarray base connector. The microarray base connector was
designed using the geometry of the microarray mold. Figure 29a is a
SolidWorksTM isometric view of the mold which serves as the starting point for
the design of the microarray base connector, Figure 29b. Figure 30 shows two
larger isometric views of the microarray base connector. Notable design features
include counter bored holes which allow for the press fitting of tubes, a "clover
leafed" geometry to mate the bottom of the part to the mold while creating ample
open surface area for outlet water flow, pins which secure the piece directly into
the four corner wells of the 96-well microarray mold, and a 200 µm cross shaped
spacer at the bottom which allows for the outflow of water, but does not provide
ample space for spheroids to jump between wells. The base connector was
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designed to incorporate transfer for only the center 24 wells of the hanging-drop
plate at first. Future iterations will incorporate all 96 wells.

Figure 29. Microarray base connector. (a) SolidWorks isometric view of the
microarray mold, the starting point for the design of the transfer device. (b)
Assembly of the microarray base connector and the cell mold.

Figure 30. Isometric views of the microarray base connector.
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5.2.2. Hanging-drop plate interface. The next part was designed to
interface a Insphero 96-well hanging drop plate to a series of tubes that would
terminate into the microarray base connector. Figure 32 depicts an isometric
view of the part.

Figure 31. Hanging-drop plate interface.

The most important design feature of this part is the array of 96
countersunk holes and three pin holders (two bottom right side, one top left side)
around the outside of the array for alignment. These were designed to work
with preexisting pins of the GravityTRAPTM system. It was designed so that
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when interfacing with a GravityTRAPTM plate, hanging spherical drops of 40 µL
would just slightly touch the hanging-drop plate interface, causing their transfer
to the interface. Additionally, the geometry of the countersunk holes was
designed to use water tension as an aid in transfer. The geometry of the holes is
such that a 40 µL drop will not pass through the plate without additional water
added on top. The countersunk holes traverse through the length of the part and
on the bottom side are the appropriate size for press fitting the thin polymer
tubes. This is extremely important for functionality of the complete system. Its
operation will be discussed in 5.3 Automated Spheroid Transfer Operation.
Other design features include a channel around the array of countersinks
which allows the press fitting of the 5.2.4 Water vat. This channel was designed
to house an O-ring which keeps the connection between these two parts water
tight. This plate also contains a hole in each corner for the addition of long
threaded rods. These rods support the device and allow for the control of the
interface's height, and thus the pressure head of the system.
At this time, only the center 24 wells of the hanging-drop plate interface
were machined through the part. The remaining holes were not drilled, but the
countersinks remain as placeholders for future design iterations.
5.2.3. PVC tubing. The system was designed to include clear PVC tubing
with inside diameter of 1/32" and outside diameter of 3/32". Clear tubing was
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used for visualization of flow and spheroid transfer. The tubing was ordered
from McMaster-Carr. Approximately 6" lengths of tubing were used. To install
the tubing, the end was cut at a 45º angle to aid press fitting. Figure 32 shows the
fitting of the center 24 tubes into the system.

Figure 32. Three views showing the connection between the two main components
of the design with tubes.

136

5.2.4 Water vat. The water vat was a late design addition once testing had
revealed that an additional pressure head would be necessary for spheroid
transfer. The vat was designed to press fit to the hanging-drop interface (which
needed slight modification), and form a water-tight seal with the help of two Orings. Figure 33 shows the system's full assembly, containing the water vat.

Figure 33. Mechanical transfer system completed assembly.
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5.3. Mechanical Spheroid Transfer Operation
The mechanical system was designed to operate as follows:
1. The microarray mold is prepared by filling its cavity with water and
removing all microbubbles as described in 3.3 Microarray Formation. It is
then attached to the microarray base connector using four pins.
2. After placement of the Insphero hanging-drop plate to the hanging-drop
interface, spheroids are transferred to the interface by contact with
hanging-drops. Due to surface tension of the culture medium, spheroids
and droplets remain in the counterbores of the hanging-drop interface
part.
3. A piece of filter paper is applied, covering all counterbores of the array.
4. The water vat is then press-fitted into the hanging-drop interface. It is
slowly filled with about one centimeter of water to increase the pressure
head, flushing the spheroids through the tubes and into the microarray
mold. Care is taken not to flush the interface too fast causing filter
dislodging or flow rates too large for the system.
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Chapter 6
Conclusion
In this study, a novel process for the high-throughput analysis of
multicellular tumor spheroids was designed, refined, and fully characterized.
The system has full capabilities to increase the throughput, speed and
effectiveness of biomedical research on spheroid cultures. Benefits of this system
include increased power of study, side-by-side staining, and efficiency.
The system designed is not completely without error, and therefore comes
with recommendations for the future. The most important error factors all have
to do with pillar pull out and orientation through processing. Other errors, such
as tilt during cutting, were shown to be acceptable, leading to a small amount of
error, and thus should be considered for improvement only once permanent
solutions to primary errors are reached.
The paramount issue with the system is the mold design which creates the
geometry of the microarray. Pillars were designed to be cylindrical, but after
thorough testing of all system parameters (gel composition, reagents, etc.)
experimental pullout reached a maximum of 90/96 spheroids per microarray
(n=2). After processing and sectioning, the maximum number of spheroids
achieved on a single slide was 84/96 (n=1). Additionally, the cylindrical pillars
allowed for a relatively large area for the spheroid to move and come to rest. The
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result were imperfect columns and rows of spheroids on slides after histology.
To solve the issue of spheroid pullout and alignment, it is recommended that a
positive mold of an array of square pyramids be used to replace the cylindrical
pillars. This would allow for much larger angles of relief during pullout, and
would also create geometry in the mold what would force spheroids to become
centralized in each well. This design would also increase the surface area for
diffusion during processing, potentially eliminating processing effects, while
promoting better mixing during agarose infiltration.
The SPION study showed the potential power of using a microarray
system to study spheroids and acquire regionally based information. Although
no publishable results were obtained from the penetration of particles into
spheroids, the power of the system was ascertained. A study which previously
would have taken a lab months to assemble, process and section 96 individual
spheroid blocks, was reduced to the processing of just two, while adding the
ability for side-by-side comparison of multiple experimental groups (without
normalization each to a stained and calibrated control).
The study did highlight a potential therapeutic dosage range between 10
µg/mL and 100 µg/mL for 5k-PEG SPIONs. Within this range, there appeared to
exist a concentration which allowed the drug to penetrate the cell membrane.
Furthermore, even without positive staining, dosage and time combinations of 3
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days and 10 µg/mL, 7 days and 1 µg/mL, and 7 days and 10 µg/mL all showed
spheroids much less dense than their control counterparts which were
disassembling and becoming necrotic. The dosage and time combination of 3
days and 1 µg/mL showed 67% normal spheroids and 33% necrotic spheroids.
All other time points less than 3 days showed no signs of necrosis.
Finally, to improve the process of spheroid embedding, a design was
successfully created that mechanically assisted spheroid transfer. The time to
setup and use the system was ~5 seconds per spheroid, a large reduction in time
compared with ~60-90 seconds per spheroid using the methods described in 3.3
3D Microarray Formation.
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Appendix
Experimental Data
Table A.1
Tilt diameter raw data
Degrees of
Tilt
0.100
0.200
0.300
0.400
0.500
0.600
0.700
0.800
0.900
1.000
1.100
1.200
1.300
1.400
1.500
1.600
1.700
1.800
1.900
2.000
2.100
2.200
2.250

24
diameter
0.500
0.498
0.496
0.492
0.492
0.482
0.475
0.468
0.458
0.448
0.437
0.423
0.409
0.392
0.373
0.352
0.329
0.301
0.270
0.231
0.183
0.111
0.037

48
diameter
0.499
0.496
0.491
0.484
0.484
0.464
0.450
0.434
0.415
0.392
0.365
0.334
0.295
0.248
0.183
0.060
0.000
0.000
0.000
0.000
0.000
0.000
0.000

96
diameter
0.498
0.490
0.478
0.460
0.437
0.405
0.365
0.313
0.240
0.111
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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Table A.2
Tilt area raw data
Degrees of
Tilt
0.100
0.200
0.300
0.400
0.500
0.600
0.700
0.800
0.900
1.000
1.100
1.200
1.300
1.400
1.500
1.600
1.700
1.800
1.900
2.000
2.100
2.200
2.250

24 area
0.196
0.195
0.193
0.190
0.190
0.182
0.177
0.172
0.165
0.158
0.150
0.141
0.131
0.121
0.110
0.098
0.085
0.071
0.057
0.042
0.026
0.010
0.001

48 area
0.196
0.193
0.190
0.184
0.184
0.169
0.159
0.148
0.135
0.121
0.105
0.087
0.069
0.048
0.026
0.003
0.000
0.000
0.000
0.000
0.000
0.000
0.000

96 area
0.194
0.189
0.180
0.166
0.150
0.129
0.105
0.077
0.045
0.010
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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Table A.3
Calculated percent differences of area
Percent Differences
24
48
Degrees of Tilt
area
area
0.000
0.100
0.200
0.300
0.400
0.500
0.600
0.700
0.800
0.900
1.000
1.100
1.200
1.300
1.400
1.500
1.600
1.700
1.800
1.900
2.000
2.100
2.200
2.250

1.000
0.998
0.992
0.982
0.969
0.969
0.929
0.904
0.874
0.841
0.803
0.762
0.717
0.668
0.615
0.558
0.497
0.432
0.363
0.291
0.214
0.134
0.049
0.006

1.000
0.996
0.985
0.965
0.938
0.938
0.861
0.811
0.753
0.688
0.615
0.534
0.445
0.349
0.245
0.134
0.014
0.000
0.000
0.000
0.000
0.000
0.000
0.000

96
area
1.000
0.990
0.962
0.914
0.848
0.762
0.658
0.534
0.391
0.230
0.049
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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Table A.4
Calculated percent error of area
Percent Error
24
48
degrees of tilt
block
block
0.000
0.100
0.200
0.300
0.400
0.500
0.600
0.700
0.800
0.900
1.000
1.100
1.200
1.300
1.400
1.500
1.600
1.700
1.800
1.900
2.000
2.100
2.200
2.250

0.000
0.002
0.008
0.018
0.031
0.031
0.071
0.096
0.126
0.159
0.197
0.238
0.283
0.332
0.385
0.442
0.503
0.568
0.637
0.709
0.786
0.866
0.951
0.994

0.000
0.004
0.015
0.035
0.062
0.062
0.139
0.189
0.247
0.312
0.385
0.466
0.555
0.651
0.755
0.866
0.986
1.000
1.000
1.000
1.000
1.000
1.000
1.000

96
block
0.000
0.010
0.038
0.086
0.152
0.238
0.342
0.466
0.609
0.770
0.951
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
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